Diagnoses of HIV Infection Among Adults Aged 50 Years and Older—United States and 6 Dependent Areas 2014–2018

HIV Surveillance Data Tables

Diagnoses of HIV Infection Among Adults Aged 50 Years and OlderUnited States and 6 Dependent Areas 2014–2018

This issue of HIV Surveillance Data Tables is published by the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, Georgia.

Data are presented for diagnoses of HIV infection reported to CDC through December 2019.

The HIV Surveillance Data Tables is not copyrighted and may be used and copied without permission. Citation of the source is, however, appreciated.

Suggested Citation

Centers for Disease Control and Prevention. Diagnoses of HIV infection among adults aged 50 years and older—United States and 6 dependent areas, 2014–2018. HIV Surveillance Data Tables 2020;1(No. 5) http://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-1-no-5/index.html. Published August 2020. Accessed [date].

Download the full report pdf icon[PDF – 10 MB].

Surveillance of HIV Infection

Persons aged 50 years and older account for a substantial number of HIV infections. Persons aged 50 years and older accounted for 17% of all diagnoses in 2018 and 51% of persons living with diagnosed HIV infection in the United States in 2018 [1]. Understanding the burden of HIV among different subgroups of older persons can help HIV programs to focus on populations and areas at greatest need for HIV prevention, treatment, and care services. Data presented for persons aged 50 years and older were reported (after the removal of personally identifiable information) to the Centers for Disease Control and Prevention (CDC) through December 2019. Please use caution when interpreting the following:

  • Data on diagnoses of HIV infection. HIV surveillance reports may not be representative of all persons with HIV because not all infected persons have been (1) tested or (2) tested at a time when the infection could be detected and diagnosed. Also, some states offer anonymous HIV testing; the results of anonymous tests are not reported to the confidential, name-based HIV registries of state and local health departments. Therefore, reports of confidential test results may not represent all persons who tested positive for HIV infection.
  • Deaths and prevalence-based data. Data for the year 2018 are considered preliminary and are based on deaths reported to CDC through December 2019.
  • Numbers less than 12, and rates and trends based on these numbers.

Data re-release agreements between CDC and state/local HIV surveillance programs require specific levels of cell suppression at the state and county level in order to ensure confidentiality of personally identifiable information.

Tabulation and Presentation of Data

The data are presented for adults aged 50 years and older with HIV infection diagnosed during 2014–2018. The tables also present data for persons living with diagnosed HIV infection (prevalence) as of December 31 of the specified year. Tables are presented in 2 formats. Tables in the first format—labeled “a”—exclude data from the dependent areas (American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, the Republic of Palau, and the U.S. Virgin Islands). Tables in the second format— labeled “b”—include data from the dependent areas.

Diagnosis of HIV Infection

Diagnoses of HIV infection are the numbers and rates of persons aged 50 years and older with HIV diagnosed during the specified years (Tables 1a/b–6). The term diagnosis of HIV infection is defined as a diagnosis of HIV infection regardless of the stage of disease (stage 0, 1, 2, 3 [AIDS], or unknown) and refers to all persons with a diagnosis of HIV infection. Data from all areas (where indicated) are included in tables displaying numbers and rates of diagnoses of HIV infection and of diagnoses of infection classified as stage 3 (AIDS) at time of HIV diagnosis (Tables 18a/b–20a/b), by selected characteristics, area of residence, and region of residence. For tables presenting diagnosis data, region or area of residence reflects the address at the time of HIV diagnosis.

More information on counting diagnoses of HIV infection can be found in the Technical Notes of the 2018 HIV Surveillance Report at https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-31/index.html.

Prevalence: Persons Living with Diagnosed HIV Infection

Prevalence trends and data reflect persons living with diagnosed HIV infection, regardless of the stage of disease, at the end of a given year during 2014–2018 (Tables 7a/b–13). For tables presenting prevalence data, region or area of residence is based on most recent known address as of the end of the specified year. Data for the year 2018 are considered preliminary and are based on death data reported to CDC through December 2019. Due to incomplete reporting of deaths for the year 2018, prevalence data for Alabama, Oklahoma, South Carolina, and the U.S. Virgin Islands should be interpreted with caution.

Deaths

Persons reported to the National HIV Surveillance System are assumed alive unless their deaths have been reported to CDC. Death data include deaths of persons with diagnosed HIV infection, regardless of the cause of death (Tables 14a/b–17a/b). Data for the year 2018 are preliminary and are based on death data reported to CDC through December 2019. For tables presenting death data, region of residence is based on residence at death. If information on residence at death was not available, the state where a person’s death occurred was used. Trends through 2018 should be interpreted with caution. Due to incomplete reporting of deaths for the year 2018, death data for Alabama, Oklahoma, South Carolina, and the U.S. Virgin Islands should be interpreted with caution.

Rates

Rates per 100,000 population were calculated for (1) the numbers of diagnoses of HIV infection, (2) the numbers of persons living with diagnosed HIV infection (prevalence), and (3) the numbers of deaths of persons with diagnosed HIV infection.

The population denominators used to compute the rates for areas in the United States and Puerto Rico were based on the Vintage 2018 postcensal estimates file from the U.S. Census Bureau (for years 2014–2018) [2]. The population denominators for American Samoa, Guam, the Northern Mariana Islands, the Republic of Palau, and the U.S. Virgin Islands were based on estimates and projections from the U.S. Census Bureau’s International Database [3]. Each rate was calculated by dividing the total number of diagnoses (or deaths or prevalence) for the calendar year by the population for that calendar year and then multiplying the result by 100,000. The denominators used for calculating the rates specific to age, sex, and race/ethnicity were computed by applying the appropriate vintage estimates for age, sex, and race/ethnicity for the 50 states and the District of Columbia [2]. The same method was used to calculate the denominators for Puerto Rico, with the exception of race/ethnicity estimates; these data are not available for Puerto Rico. For the other 5 U.S. dependent areas, estimates from the U.S. Census Bureau’s International Data Base were used for age- and sex-specific population denominators [3].

CDC currently does not provide subpopulation rates by race/ethnicity for the 6 dependent areas because the U.S. Census Bureau does not collect information from all U.S. dependent areas. Rates for gender and transmission categories are not provided because of the absence of denominator data from the U.S. Census Bureau, the source of data used for calculating all rates in the tables.

Age

The designation “older adults” refers to persons aged 50 years and older. For tables presenting diagnosis data, the age-group assignment (e.g., 50–64 years) or age designation (i.e., older adults) is based on the person’s age at the time of diagnosis (HIV infection or infection classified as stage 3 [AIDS] at time of HIV diagnosis). For presentations of data on older adults living with diagnosed HIV infection (Tables 7a/b–13), specific age-group assignment or age designation is based on the person’s age as of December 31 of the specified year. For tables presenting death data of persons with diagnosed HIV infection (Tables 14a/b–17a/b), specific age-group assignment or age designation is based on the person’s age at the time of death.

Geographic Designations: U.S. Regions

Geographic designations reflect the region or area of residence at the time of diagnosis of HIV infection for tables presenting diagnosis data (Tables 1a/b–6, 18a/b–20a/b). Prevalence data reflect the region or area of residence based on the most recent known address as of the end of the specified year (Tables 7a/b–13). Death data reflect the region or area of residence based on residence at death (Tables 14a/b–17a/b).

Map of US census regions. The 4 regions of residence used in this report are defined by the U.S. Census Bureau as follows: •	Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont •	Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin •	South: Alabama, Arkansas, Delaware, District of Columbia (D.C.), Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia •	West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming

The 4 regions of residence and 6 dependent areas used in this report are defined by the U.S. Census Bureau as follows:

Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont

Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin

South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia

West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming

U.S. dependent areas: American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, the Republic of Palau, and the U.S. Virgin Islands

Metropolitan Statistical Areas

In the Federal Register for June 28, 2010, the Office of Management and Budget (OMB) published revised standards for defining metropolitan statistical areas (MSAs) in federal statistical activities [4]. These standards, which provided for the identification of MSAs in the United States and Puerto Rico, replaced the 2000 standards. The adoption of the new standards was effective as of June 28, 2010. On February 28, 2013, OMB announced new MSA delineations based on the new standards and Census 2010 data [5]. Table 13 (Adults aged 50 years and older living with diagnosed HIV infection, by population of area of residence, age group, and selected characteristics, year-end 2018—United States) presents the number and rate of prevalence by MSA. The MSAs listed in these tables were defined according to OMB’s most recent update (February 2013) of statistical areas [5].

References

  1. HIV Surveillance Report, 2018 (Updated); vol. 31. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2020. Accessed June 15, 2020.
  2. S. Census Bureau. Population and Housing Unit Estimates Datasets. https://go.usa.gov/xn4ccexternal icon. Accessed June 15, 2020.
  3. S. Census Bureau. International Data Base. http://www.census.gov/data-tools/demo/idb/external iconinformation-Gateway.php. Updated December 2019. Accessed June 15, 2020.
  4. Office of Management and Budget. 2010 Standards for delineating metropolitan and micropolitan statistical areas. Federal Register 2010;75(123):37246–39052. http://www.gpo.gov/fdsys/pkg/FR-2010-06-28/html/2010-15605.htmexternal icon. Accessed June 15, 2020.
  5. Office of Management and Budget. Revised delineations of metropolitan statistical areas, micropolitan statistical areas, and combined statistical areas, and guidance on uses of the delineations of these areas. OMB Bulletin 13-01. https://go.usa.gov/xQWPhexternal icon. Published February 28, 2013. Accessed June 15, 2020.

Suggested Citation

Centers for Disease Control and Prevention. Diagnoses of HIV infection among adults aged 50 years and older—United States and 6 dependent areas, 2014–2018. HIV Surveillance Data Tables 2020;1(No. 5) http://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-1-no-5/index.html. Published August 2020. Accessed [date].

Acknowledgments

Publication of HIV Surveillance Data Tables was made possible by the contributions of the state and territorial health departments and the HIV surveillance programs that provided surveillance data to CDC.

HIV Surveillance Data Tables was prepared by the following staff and contractors of the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC: Shacara Johnson Lyons, Laurie Linley, Jianmin Li, Chenchen Yu, André Dailey, Anna Satcher Johnson, and Michael Friend and the Web and Consumer Services Team of the Prevention Communications Branch (editing and desktop publishing).

Table 1a. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis and selected characteristics, 2014–2018—United States
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 4,843 4,899 4,806 4,633 4,444
Female 1,749 1,805 1,877 1,831 1,784
Transgender male-to-femaleb 15 25 20 18 13
Transgender female-to-maleb 1 1 0 1 1
Additional gender identityc 0 0 1 0 0
Age at diagnosis (yr)
50–54 2,885 12.8 2,998 13.5 2,875 13.2 2,652 12.4 2,476 11.9
55–59 1,923 9.0 1,883 8.7 1,894 8.6 1,877 8.5 1,849 8.4
60–64 969 5.2 999 5.3 1,081 5.6 1,083 5.4 1,039 5.1
65–69 523 3.4 537 3.3 562 3.3 517 3.1 489 2.9
70–74 186 1.7 197 1.7 188 1.6 225 1.8 249 1.9
75–79 86 1.1 82 1.0 68 0.8 88 1.0 93 1.0
80–84 28 0.5 28 0.5 26 0.4 33 0.6 33 0.5
≥85 8 0.1 6 0.1 10 0.2 8 0.1 14 0.2
Race/Ethnicity
American Indian/Alaska Native 26 3.9 24 3.5 30 4.3 33 4.6 30 4.1
Asian 104 2.2 106 2.1 125 2.4 119 2.2 115 2.0
Black/African American 2,801 25.0 2,776 24.1 2,760 23.4 2,708 22.5 2,567 20.9
Hispanic/Latinod 1,099 10.5 1,193 10.9 1,193 10.4 1,173 9.8 1,271 10.1
Native Hawaiian/other Pacific Islander 7 5.5 11 8.2 8 5.7 4 2.7 9 5.9
White 2,370 2.9 2,415 3.0 2,404 2.9 2,294 2.8 2,127 2.6
Multiple races 201 21.4 205 21.1 184 18.3 152 14.6 123 11.5
Transmission Categorye
Male adultf
Male-to-male sexual contact 3,171 3,224 3,195 3,113 2,978
Injection drug use 430 411 396 375 378
Male-to-male sexual contact and injection drug use 172 176 172 168 149
Heterosexual contactg 1,074 1,101 1,052 983 939
Otherh 11 12 12 12 13
Subtotal 4,858 9.6 4,924 9.5 4,826 9.2 4,651 8.7 4,457 8.3
Female adultf
Injection drug use 257 249 276 244 246
Heterosexual contactg 1,489 1,553 1,597 1,585 1,534
Otherh 4 4 4 4 5
Subtotal 1,750 3.0 1,806 3.1 1,878 3.1 1,832 3.0 1,785 2.9
Region of residencei
Northeast 1,389 6.8 1,344 6.5 1,242 6.0 1,170 5.6 1,153 5.4
Midwest 714 3.0 775 3.2 813 3.3 774 3.1 735 3.0
South 3,304 8.2 3,371 8.2 3,345 7.9 3,295 7.7 3,195 7.3
West 1,201 5.0 1,240 5.0 1,304 5.2 1,244 4.9 1,159 4.4
Total 6,608 6.1 6,730 6.1 6,704 6.0 6,483 5.7 6,242 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dHispanics/Latinos can be of any race.
eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
fData presented based on sex at birth and include transgender persons.
gHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
iData are based on residence at time of diagnosis of HIV infection.

Table 1b. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis and selected characteristics, 2014–2018—United States and 6 dependent areas
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 4,949 4,997 4,918 4,727 4,535
Female 1,788 1,843 1,909 1,863 1,814
Transgender male-to-femaleb 15 25 20 18 13
Transgender female-to-maleb 1 1 0 1 1
Additional gender identityc 0 0 1 0 0
Age at diagnosis (yr)
50–54 2,931 12.9 3,056 13.6 2,920 13.2 2,703 12.5 2,528 12.0
55–59 1,968 9.1 1,915 8.7 1,944 8.8 1,911 8.6 1,877 8.5
60–64 996 5.3 1,014 5.3 1,106 5.6 1,103 5.5 1,058 5.1
65–69 537 3.5 559 3.4 579 3.4 525 3.1 502 2.9
70–74 195 1.7 204 1.8 191 1.6 231 1.8 255 1.9
75–79 88 1.1 84 1.0 70 0.8 92 1.0 95 1.0
80–84 28 0.5 28 0.5 27 0.5 35 0.6 33 0.5
≥85 10 0.2 6 0.1 11 0.2 9 0.1 15 0.2
Race/Ethnicity
American Indian/Alaska Native 26 24 30 33 30
Asian 105 106 125 119 115
Black/African American 2,811 2,778 2,762 2,708 2,569
Hispanic/Latinod 1,231 1,324 1,334 1,296 1,387
Native Hawaiian/other Pacific Islander 7 12 9 6 10
White 2,372 2,417 2,404 2,295 2,129
Multiple races 201 205 184 152 123
Transmission Categorye
Male adultf
Male-to-male sexual contact 3,199 3,264 3,241 3,151 3,019
Injection drug use 455 432 414 397 389
Male-to-male sexual contact and injection drug use 174 181 172 168 152
Heterosexual contactg 1,125 1,133 1,100 1,016 975
Otherh 11 12 12 12 13
Subtotal 4,964 9.7 5,022 9.6 4,938 9.3 4,745 8.8 4,548 8.3
Female adultf
Injection drug use 260 250 279 247 246
Heterosexual contactg 1,525 1,590 1,627 1,613 1,564
Otherh 4 4 4 4 5
Subtotal 1,789 3.0 1,844 3.1 1,910 3.1 1,864 3.0 1,815 2.9
Region of residencei
Northeast 1,389 6.8 1,344 6.5 1,242 6.0 1,170 5.6 1,153 5.4
Midwest 714 3.0 775 3.2 813 3.3 774 3.1 735 3.0
South 3,304 8.2 3,371 8.2 3,345 7.9 3,295 7.7 3,195 7.3
West 1,201 5.0 1,240 5.0 1,304 5.2 1,244 4.9 1,159 4.4
U.S. dependent areas 145 10.4 136 9.7 144 10.2 126 8.9 121 8.5
Total 6,753 6.1 6,866 6.1 6,848 6.0 6,609 5.7 6,363 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dHispanics/Latinos can be of any race.
eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
fData presented based on sex at birth and include transgender persons.
gHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
iData are based on residence at time of diagnosis of HIV infection.

Table 2a. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis, sex at birth, and selected characteristics, 2014–2018—United States
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Age at diagnosis (yr)
50–54 2,193 19.8 2,252 20.6 2,144 20.0 1,990 19.0 1,813 17.6
55–59 1,335 12.8 1,347 12.8 1,323 12.4 1,312 12.3 1,299 12.2
60–64 700 7.9 700 7.7 736 7.9 749 7.9 717 7.4
65–69 388 5.4 385 5.1 408 5.1 365 4.6 352 4.4
70–74 143 2.8 154 2.9 142 2.6 152 2.6 177 2.8
75–79 71 2.0 64 1.8 52 1.4 53 1.4 65 1.6
80–84 25 1.1 16 0.7 17 0.7 25 1.0 24 0.9
≥85 3 0.1 6 0.3 4 0.2 5 0.2 10 0.4
Race/Ethnicity
American Indian/Alaska Native 17 5.5 14 4.4 20 6.1 21 6.3 23 6.8
Asian 79 3.7 81 3.6 98 4.2 84 3.5 85 3.4
Black/African American 1,695 34.4 1,671 33.0 1,618 31.2 1,576 29.8 1,498 27.8
Hispanic/Latinob 829 16.9 924 17.9 903 16.6 912 16.1 959 16.1
Native Hawaiian/other Pacific Islander 4 6.5 9 13.9 4 5.9 3 4.3 7 9.5
White 2,084 5.5 2,078 5.4 2,050 5.3 1,940 5.0 1,802 4.6
Multiple races 150 34.4 147 32.5 133 28.5 115 23.9 83 16.7
Region of residencec
Northeast 993 10.6 926 9.8 832 8.7 765 7.9 774 7.9
Midwest 553 5.0 594 5.3 625 5.5 585 5.1 574 4.9
South 2,344 12.5 2,381 12.4 2,311 11.8 2,286 11.5 2,204 10.9
West 968 8.5 1,023 8.8 1,058 8.9 1,015 8.4 905 7.3
Subtotal, male adult 4,858 9.6 4,924 9.5 4,826 9.2 4,651 8.7 4,457 8.3
Female adult
Age at diagnosis (yr)
50–54 692 6.0 746 6.6 731 6.6 662 6.1 663 6.3
55–59 588 5.3 536 4.8 571 5.1 565 5.0 550 4.9
60–64 269 2.8 299 3.0 345 3.4 334 3.2 322 3.0
65–69 135 1.7 152 1.8 154 1.7 152 1.7 137 1.5
70–74 43 0.7 43 0.7 46 0.7 73 1.1 72 1.0
75–79 15 0.3 18 0.4 16 0.3 35 0.7 28 0.5
80–84 3 0.1 12 0.4 9 0.3 8 0.2 9 0.3
≥85 5 0.1 0 0.0 6 0.1 3 0.1 4 0.1
Race/Ethnicity
American Indian/Alaska Native 9 2.5 10 2.7 10 2.7 12 3.1 7 1.8
Asian 25 0.9 25 0.9 27 0.9 35 1.2 30 1.0
Black/African American 1,106 17.6 1,105 17.1 1,142 17.3 1,132 16.8 1,069 15.5
Hispanic/Latinob 270 4.9 269 4.6 290 4.8 261 4.1 312 4.7
Native Hawaiian/other Pacific Islander 3 4.5 2 2.9 4 5.5 1 1.3 2 2.5
White 286 0.7 337 0.8 354 0.8 354 0.8 325 0.7
Multiple races 51 10.1 58 11.1 51 9.5 37 6.6 40 7.0
Region of residencec
Northeast 396 3.6 418 3.8 410 3.7 405 3.6 379 3.3
Midwest 161 1.3 181 1.4 188 1.5 189 1.4 161 1.2
South 960 4.4 990 4.5 1,034 4.6 1,009 4.4 991 4.2
West 233 1.8 217 1.7 246 1.9 229 1.7 254 1.9
Subtotal, female adult 1,750 3.0 1,806 3.1 1,878 3.1 1,832 3.0 1,785 2.9
Total 6,608 6.1 6,730 6.1 6,704 6.0 6,483 5.7 6,242 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population.
bHispanics/Latinos can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 2b. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis, sex at birth, and selected characteristics, 2014–2018—United States and 6 dependent areas
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Age at diagnosis (yr)
50–54 2,226 19.9 2,295 20.8 2,181 20.1 2,029 19.1 1,853 17.8
55–59 1,366 13.0 1,368 12.8 1,359 12.6 1,335 12.4 1,319 12.2
60–64 723 8.1 714 7.8 754 8.0 764 7.9 732 7.4
65–69 398 5.4 397 5.2 423 5.3 372 4.6 362 4.5
70–74 148 2.9 160 3.0 145 2.6 155 2.6 181 2.9
75–79 73 2.1 66 1.8 54 1.4 57 1.4 66 1.6
80–84 25 1.0 16 0.7 18 0.7 27 1.1 24 0.9
≥85 5 0.2 6 0.3 4 0.2 6 0.3 11 0.5
Race/Ethnicity
American Indian/Alaska Native 17 14 20 21 23
Asian 80 81 98 84 85
Black/African American 1,702 1,671 1,620 1,576 1,500
Hispanic/Latinob 926 1,019 1,012 1,004 1,045
Native Hawaiian/other Pacific Islander 4 10 5 5 8
White 2,085 2,080 2,050 1,940 1,804
Multiple races 150 147 133 115 83
Region of residencec
Northeast 993 10.6 926 9.8 832 8.7 765 7.9 774 7.9
Midwest 553 5.0 594 5.3 625 5.5 585 5.1 574 4.9
South 2,344 12.5 2,381 12.4 2,311 11.8 2,286 11.5 2,204 10.9
West 968 8.5 1,023 8.8 1,058 8.9 1,015 8.4 905 7.3
U.S. dependent areas 106 17.0 98 15.5 112 17.6 94 14.7 91 14.2
Subtotal, male adult 4,964 9.7 5,022 9.6 4,938 9.3 4,745 8.8 4,548 8.3
Female adult
Age at diagnosis (yr)
50–54 705 6.1 761 6.6 739 6.6 674 6.1 675 6.3
55–59 602 5.4 547 4.8 585 5.1 576 5.0 558 4.9
60–64 273 2.8 300 3.0 352 3.4 339 3.2 326 3.0
65–69 139 1.7 162 1.9 156 1.7 153 1.7 140 1.5
70–74 47 0.8 44 0.7 46 0.7 76 1.1 74 1.0
75–79 15 0.3 18 0.4 16 0.3 35 0.7 29 0.6
80–84 3 0.1 12 0.3 9 0.3 8 0.2 9 0.3
≥85 5 0.1 0 0.0 7 0.2 3 0.1 4 0.1
Race/Ethnicity
American Indian/Alaska Native 9 10 10 12 7
Asian 25 25 27 35 30
Black/African American 1,109 1,107 1,142 1,132 1,069
Hispanic/Latinob 305 305 322 292 342
Native Hawaiian/other Pacific Islander 3 2 4 1 2
White 287 337 354 355 325
Multiple races 51 58 51 37 40
Region of residencec
Northeast 396 3.6 418 3.8 410 3.7 405 3.6 379 3.3
Midwest 161 1.3 181 1.4 188 1.5 189 1.4 161 1.2
South 960 4.4 990 4.5 1,034 4.6 1,009 4.4 991 4.2
West 233 1.8 217 1.7 246 1.9 229 1.7 254 1.9
U.S. dependent areas 39 5.1 38 4.9 32 4.1 32 4.1 30 3.9
Subtotal, female adult 1,789 3.0 1,844 3.1 1,910 3.1 1,864 3.0 1,815 2.9
Total 6,753 6.1 6,866 6.1 6,848 6.0 6,609 5.7 6,363 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited.
bHispanics/Latinos can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 3a. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis, age group, sex at birth, and selected characteristics, 2014–2018—United States
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Race/Ethnicity
American Indian/Alaska Native 16 7.8 14 6.7 17 8.1 18 8.6 20 9.5
Asian 64 4.8 71 5.2 79 5.6 73 5.0 68 4.6
Black/African American 1,451 43.7 1,449 43.0 1,394 40.9 1,362 39.7 1,271 36.8
Hispanic/Latinob 740 21.8 812 22.8 809 21.8 796 20.6 849 21.1
Native Hawaiian/Other Pacific 3 7.2 9 20.8 2 4.5 2 4.4 6 12.8
White 1,822 8.4 1,821 8.4 1,780 8.2 1,695 7.9 1,545 7.3
Multiple races 132 45.1 123 41.1 122 40.0 105 33.9 70 22.2
Transmission Categoryc 
Male-to-male sexual contact 2,811 2,875 2,855 2,774 2,596
Injection drug use 369 354 333 316 328
Male-to-male sexual contact and injection drug use 164 165 154 153 137
Heterosexual contactd 879 900 856 802 760
Othere 5 6 5 6 8
Region of residencef
Northeast 836 14.9 792 14.0 706 12.5 654 11.6 662 11.8
Midwest 496 7.3 531 7.9 568 8.4 514 7.7 499 7.5
South 2,038 18.4 2,068 18.4 1,996 17.6 1,981 17.4 1,893 16.6
West 858 12.5 908 13.1 933 13.4 902 12.9 775 11.1
Subtotal, male aged 50–64 years 4,228 13.9 4,299 14.1 4,203 13.7 4,051 13.2 3,829 12.5
Female adult
Race/Ethnicity
American Indian/Alaska Native 9 4.0 9 3.9 9 3.9 11 4.7 7 3.0
Asian 24 1.5 20 1.2 22 1.3 30 1.7 23 1.3
Black/African American 963 24.8 955 24.2 1,003 25.2 943 23.5 921 22.8
Hispanic/Latinob 240 6.8 236 6.4 245 6.4 220 5.5 261 6.3
Native Hawaiian/other Pacific Islander 3 6.9 2 4.4 4 8.6 1 2.1 2 4.1
White 264 1.2 306 1.4 322 1.4 324 1.5 292 1.3
Multiple races 46 14.3 53 16.0 42 12.4 32 9.3 29 8.3
Transmission Categoryc
Injection drug use 224 222 246 215 218
Heterosexual contactd 1,322 1,357 1,398 1,344 1,315
Othere 2 2 3 3 3
Region of residencef
Northeast 332 5.5 363 6.0 352 5.8 344 5.7 323 5.4
Midwest 142 2.0 160 2.3 173 2.5 169 2.4 140 2.0
South 863 7.2 871 7.2 901 7.4 841 6.9 860 7.0
West 212 2.9 187 2.6 221 3.0 207 2.8 212 2.9
Subtotal, female aged 50–64 years 1,549 4.8 1,581 4.9 1,647 5.1 1,561 4.8 1,535 4.7
Both sexes
Race/Ethnicity
American Indian/Alaska Native 25 5.8 23 5.2 26 5.9 29 6.5 27 6.1
Asian 88 3.0 91 3.0 101 3.3 103 3.2 91 2.8
Black/African American 2,414 33.5 2,404 32.9 2,397 32.4 2,305 30.9 2,192 29.3
Hispanic/Latinob 980 14.1 1,048 14.5 1,054 13.9 1,016 12.9 1,110 13.6
Native Hawaiian/other Pacific Islander 6 7.0 11 12.4 6 6.6 3 3.2 8 8.3
White 2,086 4.7 2,127 4.8 2,102 4.8 2,019 4.6 1,837 4.3
Multiple races 178 29.0 176 27.9 164 25.5 137 20.9 99 14.9
Region of residencef
Northeast 1,168 10.0 1,155 9.9 1,058 9.0 998 8.6 985 8.5
Midwest 638 4.6 691 5.0 741 5.4 683 5.0 639 4.7
South 2,901 12.6 2,939 12.6 2,897 12.3 2,822 11.9 2,753 11.6
West 1,070 7.6 1,095 7.7 1,154 8.1 1,109 7.8 987 6.9
Subtotal, aged 50–64 years 5,777 9.2 5,880 9.3 5,850 9.3 5,612 8.9 5,364 8.5
Aged ≥65 years of age at diagnosis
Male adult
Race/Ethnicity
American Indian/Alaska Native 1 1.0 0 0.0 3 2.6 3 2.4 3 2.3
Asian 15 1.9 10 1.2 19 2.1 11 1.1 17 1.7
Black/African American 244 15.2 222 13.2 224 12.7 214 11.6 227 11.8
Hispanic/Latinob 89 5.9 112 6.9 94 5.5 116 6.4 110 5.7
Native Hawaiian/other Pacific Islander 1 5.1 0 0.0 2 8.7 1 4.0 1 3.8
White 262 1.6 257 1.5 270 1.6 245 1.4 257 1.4
Multiple races 18 12.6 24 15.7 11 6.8 10 5.8 13 7.2
Transmission Categoryc
Male-to-male sexual contact 360 350 340 339 382
Injection drug use 61 57 63 59 50
Male-to-male sexual contact and injection drug use 9 12 18 15 12
Heterosexual contactd 195 201 196 181 179
Othere 6 6 7 6 5
Region of residencef
Northeast 157 4.2 134 3.5 126 3.2 111 2.7 112 2.7
Midwest 57 1.3 63 1.4 57 1.2 71 1.5 75 1.5
South 306 4.0 313 3.9 315 3.8 305 3.6 311 3.5
West 110 2.4 115 2.4 125 2.5 113 2.2 130 2.4
Subtotal, male aged ≥65 years 630 3.1 625 3.0 623 2.9 600 2.7 628 2.7
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 1 0.7 1 0.7 1 0.7 0 0.0
Asian 1 0.1 5 0.4 5 0.4 5 0.4 7 0.5
Black/African American 143 5.9 150 6.0 139 5.3 189 6.9 148 5.2
Hispanic/Latinob 30 1.5 33 1.6 45 2.0 41 1.7 51 2.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 22 0.1 31 0.2 32 0.2 30 0.1 33 0.1
Multiple races 5 2.8 5 2.6 9 4.5 5 2.4 11 4.9
Transmission Categoryc
Injection drug use 33 27 30 29 29
Heterosexual contactd 167 196 200 241 219
Othere 2 2 1 1 2
Region of residencef
Northeast 64 1.3 55 1.1 58 1.1 61 1.2 56 1.0
Midwest 19 0.3 21 0.4 15 0.3 20 0.3 21 0.3
South 97 1.0 119 1.2 133 1.3 168 1.6 131 1.2
West 21 0.4 30 0.5 25 0.4 22 0.4 42 0.7
Subtotal, female aged ≥65 years 201 0.8 225 0.8 231 0.8 271 1.0 250 0.9
Both sexes
Race/Ethnicity
American Indian/Alaska Native 1 0.4 1 0.4 4 1.5 4 1.5 3 1.0
Asian 16 0.9 15 0.8 24 1.1 16 0.7 24 1.0
Black/African American 387 9.6 372 8.9 363 8.3 403 8.8 375 7.9
Hispanic/Latinob 119 3.4 145 3.9 139 3.5 157 3.8 161 3.6
Native Hawaiian/other Pacific Islander 1 2.4 0 0.0 2 4.1 1 1.9 1 1.8
White 284 0.8 288 0.8 302 0.8 275 0.7 290 0.7
Multiple races 23 7.1 29 8.4 20 5.5 15 3.9 24 5.9
Region of residencef
Northeast 221 2.5 189 2.1 184 2.0 172 1.8 168 1.8
Midwest 76 0.8 84 0.8 72 0.7 91 0.8 96 0.9
South 403 2.3 432 2.4 448 2.4 473 2.5 442 2.2
West 131 1.3 145 1.4 150 1.4 135 1.2 172 1.5
Subtotal, aged ≥65 years 831 1.8 850 1.8 854 1.7 871 1.7 878 1.7
Total 6,608 6.1 6,730 6.1 6,704 6.0 6,483 5.7 6,242 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
bHispanics/Latinos can be of any race.
cData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
eIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
fData are based on residence at time of diagnosis of HIV infection.

Table 3b. Diagnoses of HIV infection among adults aged 50 years and older, by year of diagnosis, age group, sex at birth, and selected characteristics, 2014–2018—United States and 6 dependent areas
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Race/Ethnicity
American Indian/Alaska Native 16 14 17 18 20
Asian 65 71 79 73 68
Black/African American 1,457 1,449 1,396 1,362 1,273
Hispanic/Latinob 819 887 897 871 919
Native Hawaiian/other Pacific Islander 3 10 3 4 7
White 1,823 1,823 1,780 1,695 1,547
Multiple races 132 123 122 105 70
Transmission Categoryc
Male-to-male sexual contact 2,835 2,909 2,899 2,809 2,634
Injection drug use 392 373 348 334 336
Male-to-male sexual contact and injection drug use 164 167 155 153 139
Heterosexual contactd 920 923 888 826 787
Othere 5 6 5 6 8
Region of residencef
Northeast 836 14.9 792 14.0 706 12.5 654 11.6 662 11.8
Midwest 496 7.3 531 7.9 568 8.4 514 7.7 499 7.5
South 2,038 18.4 2,068 18.4 1,996 17.6 1,981 17.4 1,893 16.6
West 858 12.5 908 13.1 933 13.4 902 12.9 775 11.1
U.S. dependent areas 87 25.5 78 22.9 91 26.8 77 22.8 75 22.6
Subtotal, male aged 50–64 years 4,315 14.1 4,377 14.2 4,294 13.8 4,128 13.3 3,904 12.6
Female adult
Race/Ethnicity
American Indian/Alaska Native 9 9 9 11 7
Asian 24 20 22 30 23
Black/African American 966 955 1,003 943 921
Hispanic/Latinob 268 263 274 247 285
Native Hawaiian/other Pacific Islander 3 2 4 1 2
White 264 306 322 325 292
Multiple races 46 53 42 32 29
Transmission Categoryc
Injection drug use 226 223 249 218 218
Heterosexual contactd 1,351 1,383 1,424 1,368 1,339
Othere 2 2 3 3 3
Region of residencef
Northeast 332 5.5 363 6.0 352 5.8 344 5.7 323 5.4
Midwest 142 2.0 160 2.3 173 2.5 169 2.4 140 2.0
South 863 7.2 871 7.2 901 7.4 841 6.9 860 7.0
West 212 2.9 187 2.6 221 3.0 207 2.8 212 2.9
U.S. dependent areas 31 7.8 27 6.8 29 7.4 28 7.2 24 6.3
Subtotal, female aged 50–64 years 1,580 4.8 1,608 4.9 1,676 5.1 1,589 4.8 1,559 4.7
Both sexes          
Race/Ethnicity
American Indian/Alaska Native 25 23 26 29 27
Asian 89 91 101 103 91
Black/African American 2,423 2,404 2,399 2,305 2,194
Hispanic/Latinob 1,087 1,150 1,171 1,118 1,204
Native Hawaiian/other Pacific Islander 6 12 7 5 9
White 2,087 2,129 2,102 2,020 1,839
Multiple races 178 176 164 137 99
Region of residencef
Northeast 1,168 10.0 1,155 9.9 1,058 9.0 998 8.6 985 8.5
Midwest 638 4.6 691 5.0 741 5.4 683 5.0 639 4.7
South 2,901 12.6 2,939 12.6 2,897 12.3 2,822 11.9 2,753 11.6
West 1,070 7.6 1,095 7.7 1,154 8.1 1,109 7.8 987 6.9
U.S. dependent areas 118 16.0 105 14.3 120 16.4 105 14.4 99 13.8
Subtotal, aged 50–64 years 5,895 9.3 5,985 9.4 5,970 9.3 5,717 8.9 5,463 8.6
Aged ≥65 years of age at diagnosis
Male adult
Race/Ethnicity
American Indian/Alaska Native 1 0 3 3 3
Asian 15 10 19 11 17
Black/African American 245 222 224 214 227
Hispanic/Latinob 107 132 115 133 126
Native Hawaiian/other Pacific Islander 1 0 2 1 1
White 262 257 270 245 257
Multiple races 18 24 11 10 13
Transmission Categoryc
Male-to-male sexual contact 365 356 342 342 385
Injection drug use 63 59 66 64 53
Male-to-male sexual contact and injection drug use 10 14 18 15 13
Heterosexual contactd 206 211 212 190 188
Othere 6 6 7 6 5
Region of residencef
Northeast 157 4.2 134 3.5 126 3.2 111 2.7 112 2.7
Midwest 57 1.3 63 1.4 57 1.2 71 1.5 75 1.5
South 306 4.0 313 3.9 315 3.8 305 3.6 311 3.5
West 110 2.4 115 2.4 125 2.5 113 2.2 130 2.4
U.S. dependent areas 19 6.7 20 6.9 21 7.1 17 5.6 16 5.2
Subtotal, male aged ≥65 years 649 3.2 645 3.0 644 2.9 617 2.7 644 2.7
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 1 1 1 0
Asian 1 5 5 5 7
Black/African American 143 152 139 189 148
Hispanic/Latinob 37 42 48 45 57
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 23 31 32 30 33
Multiple races 5 5 9 5 11
Transmission Categoryc
Injection drug use 34 27 30 29 29
Heterosexual contactd 174 207 203 245 225
Othere 2 2 1 1 2
Region of residencef
Northeast 64 1.3 55 1.1 58 1.1 61 1.2 56 1.0
Midwest 19 0.3 21 0.4 15 0.3 20 0.3 21 0.3
South 97 1.0 119 1.2 133 1.3 168 1.6 131 1.2
West 21 0.4 30 0.5 25 0.4 22 0.4 42 0.7
U.S. dependent areas 8 2.2 11 2.9 3 0.8 4 1.0 6 1.5
Subtotal, female aged ≥65 years 209 0.8 236 0.9 234 0.8 275 1.0 256 0.9
Both sexes          
Race/Ethnicity
American Indian/Alaska Native 1 1 4 4 3
Asian 16 15 24 16 24
Black/African American 388 374 363 403 375
Hispanic/Latinob 144 174 163 178 183
Native Hawaiian/other Pacific Islander 1 0 2 1 1
White 285 288 302 275 290
Multiple races 23 29 20 15 24
Region of residencef
Northeast 221 2.5 189 2.1 184 2.0 172 1.8 168 1.8
Midwest 76 0.8 84 0.8 72 0.7 91 0.8 96 0.9
South 403 2.3 432 2.4 448 2.4 473 2.5 442 2.2
West 131 1.3 145 1.4 150 1.4 135 1.2 172 1.5
U.S. dependent areas 27 4.1 31 4.6 24 3.5 21 3.0 22 3.1
Subtotal, aged ≥65 years 858 1.8 881 1.8 878 1.8 892 1.7 900 1.7
Total 6,753 6.1 6,866 6.1 6,848 6.0 6,609 5.7 6,363 5.4

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
bHispanics/Latinos can be of any race.
cData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
eIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
fData are based on residence at time of diagnosis of HIV infection.

50–54

Table 4a. Diagnoses of HIV infection among adults aged 50-54 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 5054 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 13 16.5 8 10.3 7 9.2 11 14.8 13 18.1
Asian 42 8.2 45 8.6 40 7.5 39 7.2 30 5.5
Black/African American 670 52.5 703 55.4 668 53.2 611 49.5 590 48.6
Hispanic/Latinob 409 28.1 467 31.0 464 29.8 441 27.6 457 27.8
Native Hawaiian/other Pacific Islander 1 6.0 6 35.2 2 11.7 2 11.7 1 5.8
White 982 12.9 962 13.0 908 12.7 832 12.0 680 10.2
Multiple races 76 66.5 61 53.5 55 48.7 54 48.2 42 37.7
Transmission Categoryc
Male-to-male sexual contact 1,524 1,605 1,532 1,453 1,253
Injection drug use 159 162 159 130 147
Male-to-male sexual contact and injection drug use 92 89 78 81 80
Heterosexual contactd 416 394 374 324 331
Othere 1 1 1 1 2
Region of residencef
Northeast 424 20.7 391 19.3 351 17.8 322 16.7 299 15.9
Midwest 255 10.6 294 12.4 286 12.5 261 11.8 264 12.3
South 1,053 25.8 1,054 25.9 1,005 25.1 944 23.9 904 23.3
West 461 18.4 513 20.7 502 20.6 463 19.3 346 14.6
Subtotal, male adult 2,193 19.8 2,252 20.6 2,144 20.0 1,990 19.0 1,813 17.6
Female adult
Race/Ethnicity
American Indian/Alaska Native 5 5.9 4 4.8 5 6.1 7 8.8 3 3.9
Asian 8 1.4 8 1.3 10 1.6 15 2.4 9 1.4
Black/African American 414 28.6 432 30.0 439 30.8 385 27.5 374 27.1
Hispanic/Latinob 107 7.3 129 8.6 115 7.4 98 6.2 124 7.7
Native Hawaiian/other Pacific Islander 1 5.8 1 5.7 4 22.7 0 0.0 1 5.7
White 135 1.7 147 1.9 140 1.9 141 2.0 141 2.1
Multiple races 22 17.4 25 19.7 18 14.3 16 12.8 11 8.8
Transmission Categoryc
Injection drug use 100 102 118 98 95
Heterosexual contactd 591 643 612 564 567
Othere 1 0 1 0 1
Region of residencef
Northeast 149 6.9 173 8.1 161 7.7 150 7.4 136 6.9
Midwest 60 2.4 73 3.0 68 2.9 64 2.8 59 2.7
South 384 9.0 414 9.7 399 9.5 360 8.7 384 9.5
West 99 3.9 86 3.4 103 4.2 88 3.6 84 3.5
Subtotal, female adult 692 6.0 746 6.6 731 6.6 662 6.1 663 6.3
Both sexes
Race/Ethnicity
American Indian/Alaska Native 18 11.0 12 7.4 12 7.6 18 11.7 16 10.7
Asian 50 4.5 53 4.7 50 4.4 54 4.6 39 3.3
Black/African American 1,084 39.8 1,135 41.9 1,107 41.3 996 37.8 964 37.2
Hispanic/Latinob 516 17.7 596 19.8 579 18.6 539 16.9 581 17.8
Native Hawaiian/other Pacific Islander 2 5.9 7 20.3 6 17.3 2 5.8 2 5.8
White 1,117 7.3 1,109 7.4 1,048 7.3 973 7.0 821 6.1
Multiple races 98 40.7 86 35.7 73 30.5 70 29.5 53 22.4
Region of residencef
Northeast 573 13.6 564 13.6 512 12.6 472 11.9 435 11.3
Midwest 315 6.4 367 7.7 354 7.7 325 7.3 323 7.4
South 1,437 17.2 1,468 17.6 1,404 17.1 1,304 16.1 1,288 16.2
West 560 11.1 599 12.0 605 12.3 551 11.4 430 9.0
Total 2,885 12.8 2,998 13.5 2,875 13.2 2,652 12.4 2,476 11.9

55–59

Table 4a. Diagnoses of HIV infection among adults aged 55-59 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 5559 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 3 4.3 6 8.3 6 8.2 3 4.1 5 6.7
Asian 13 2.9 20 4.3 25 5.3 22 4.5 21 4.2
Black/African American 516 44.8 492 41.7 456 38.1 470 39.1 432 35.8
Hispanic/Latinob 215 19.1 248 20.9 225 18.1 236 18.2 270 19.9
Native Hawaiian/other Pacific Islander 0 0.0 3 20.1 0 0 0 0.0 4 24.4
White 548 7.3 538 7.1 569 7.5 550 7.3 551 7.4
Multiple races 40 39.7 40 38.5 42 39.3 31 28.5 16 14.5
Transmission Categoryc
Male-to-male sexual contact 854 849 887 868 879
Injection drug use 131 127 105 119 114
Male-to-male sexual contact and injection drug use 49 55 49 46 40
Heterosexual contactd 299 313 280 278 262
Othere 2 2 2 2 4
Region of residencef
Northeast 277 14.2 282 14.3 226 11.4 202 10.3 234 12.0
Midwest 162 6.9 155 6.6 187 7.9 171 7.3 148 6.4
South 637 16.8 650 16.9 628 16.1 652 16.6 644 16.2
West 259 11.0 260 10.9 282 11.7 287 11.9 273 11.3
Subtotal, male adult 1,335 12.8 1,347 12.8 1,323 12.4 1,312 12.3 1,299 12.2
Female adult
Race/Ethnicity
American Indian/Alaska Native 3 3.8 4 5 2 2.4 2 2.4 3 3.6
Asian 10 1.9 4 0.7 8 1.4 8 1.4 9 1.5
Black/African American 375 28.0 321 23.4 347 25 334 24.0 343 24.5
Hispanic/Latinob 90 7.6 69 5.6 83 6.4 75 5.6 83 6.0
Native Hawaiian/other Pacific Islander 1 6.8 1 6.5 0 0.0 1 6.0 1 5.8
White 96 1.2 115 1.5 112 1.4 132 1.7 102 1.3
Multiple races 13 11.8 22 19.3 19 16.2 13 10.8 9 7.4
Transmission Categoryc
Injection drug use 87 77 80 74 76
Heterosexual contactd 500 458 491 490 473
Othere 1 1 1 1 1
Region of residencef
Northeast 137 6.6 111 5.3 119 5.7 117 5.6 113 5.4
Midwest 62 2.5 59 2.4 65 2.6 75 3.1 57 2.4
South 320 7.8 303 7.3 305 7.3 294 7.0 300 7.1
West 69 2.8 63 2.5 82 3.3 79 3.1 80 3.2
Subtotal, female adult 588 5.3 536 4.8 571 5.1 565 5.0 550 4.9
Both sexes
Race/Ethnicity
American Indian/Alaska Native 6 4.0 10 6.5 8 5.2 5 3.2 8 5.1
Asian 23 2.3 24 2.4 33 3.2 30 2.8 30 2.7
Black/African American 891 35.7 813 31.9 803 31.1 804 31.0 775 29.7
Hispanic/Latinob 305 13.2 317 13.1 308 12.2 311 11.8 353 12.8
Native Hawaiian/other Pacific Islander 1 3.5 4 13.2 0 0.0 1 3.1 5 14.9
White 644 4.2 653 4.3 681 4.4 682 4.5 653 4.3
Multiple races 53 25.1 62 28.4 61 27.2 44 19.3 25 10.8
Region of residencef
Northeast 414 10.3 393 9.7 345 8.5 319 7.9 347 8.6
Midwest 224 4.7 214 4.4 252 5.2 246 5.1 205 4.3
South 957 12.2 953 11.9 933 11.5 946 11.6 944 11.5
West 328 6.8 323 6.6 364 7.4 366 7.4 353 7.1
Total 1,923 9.0 1,883 8.7 1,894 8.6 1,877 8.5 1,849 8.4

60–64

Table 4a. Diagnoses of HIV infection among adults aged 60-64 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 6064 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 4 6.7 4 6.4 2 3.1
Asian 9 2.4 6 1.5 14 3.4 12 2.8 17 3.8
Black/African American 265 29.8 254 27.5 270 28.2 281 28.2 249 24.1
Hispanic/Latinob 116 14.3 97 11.2 120 13.1 119 12.3 122 11.9
Native Hawaiian/other Pacific Islander 2 18.4 0 0.0 0 0.0 0 0.0 1 7.5
White 292 4.4 321 4.7 303 4.4 313 4.5 314 4.4
Multiple races 16 20.7 22 27.1 25 29.3 20 22.4 12 12.9
Transmission Categoryc
Male-to-male sexual contact 433 420 436 453 464
Injection drug use 79 64 69 68 68
Male-to-male sexual contact and injection drug use 22 21 27 26 18
Heterosexual contactd 164 192 202 200 167
Othere 2 3 2 3 2
Region of residencef
Northeast 135 8.3 119 7.1 129 7.6 130 7.5 129 7.3
Midwest 79 4.0 82 4.0 95 4.6 82 3.9 87 4.0
South 348 10.8 364 11.0 363 10.7 385 11.0 345 9.6
West 138 6.8 135 6.5 149 7.0 152 7.0 156 7.1
Subtotal, male adult 700 7.9 700 7.7 736 7.9 749 7.9 717 7.4
Female adult
Race/Ethnicity
American Indian/Alaska Native 1 1.6 1 1.5 2 2.9 2 2.8 1 1.4
Asian 6 1.3 8 1.6 4 0.8 7 1.3 5 0.9
Black/African American 174 15.9 202 17.8 217 18.5 224 18.4 204 16.3
Hispanic/Latinob 43 4.8 38 4.0 47 4.7 47 4.4 54 4.8
Native Hawaiian/other Pacific Islander 1 8.6 0 0.0 0 0.0 0 0.0 0 0.0
White 33 0.5 44 0.6 70 1.0 51 0.7 49 0.7
Multiple races 11 12.9 6 6.7 5 5.3 3 3.0 9 8.7
Transmission Categoryc
Injection drug use 37 43 49 43 46
Heterosexual contactd 232 256 295 290 275
Othere 1 1 1 1 1
Region of residencef
Northeast 46 2.6 79 4.3 72 3.9 77 4.1 74 3.8
Midwest 20 0.9 28 1.3 40 1.8 30 1.3 24 1.0
South 159 4.4 154 4.2 197 5.2 187 4.8 176 4.4
West 44 2.0 38 1.7 36 1.6 40 1.7 48 2.0
Subtotal, female adult 269 2.8 299 3.0 345 3.4 334 3.2 322 3.0
Both sexes
Race/Ethnicity
American Indian/Alaska Native 1 0.8 1 0.8 6 4.7 6 4.5 3 2.2
Asian 15 1.8 14 1.6 18 2.0 19 2.0 22 2.2
Black/African American 439 22.1 456 22.2 487 22.9 505 22.8 453 19.8
Hispanic/Latinob 159 9.3 135 7.4 167 8.7 166 8.2 176 8.2
Native Hawaiian/other Pacific Islander 3 13.3 0 0.0 0 0.0 0 0.0 1 3.6
White 325 2.4 365 2.6 373 2.6 364 2.5 363 2.5
Multiple races 27 16.6 28 16.4 30 16.7 23 12.1 21 10.6
Region of residencef
Northeast 181 5.3 198 5.7 201 5.6 207 5.7 203 5.5
Midwest 99 2.4 110 2.6 135 3.1 112 2.6 111 2.5
South 507 7.4 518 7.4 560 7.8 572 7.7 521 6.9
West 182 4.3 173 4.0 185 4.2 192 4.2 204 4.4
Total 969 5.2 999 5.3 1,081 5.6 1,083 5.4 1,039 5.1

65–69

Table 4a. Diagnoses of HIV infection among adults aged 65-69 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 6569 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 1 2.1 2 4.1 2 4.0
Asian 11 3.8 7 2.2 9 2.7 6 1.7 8 2.2
Black/African American 153 24.2 138 20.4 145 20.1 128 17.3 123 16.1
Hispanic/Latinob 56 9.7 67 10.8 59 8.9 74 10.7 60 8.3
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 1 10.6 0 0.0 1 9.6
White 160 2.8 155 2.6 187 3.1 149 2.5 149 2.5
Multiple races 8 14.1 18 29.6 6 9.3 6 9.0 9 13.0
Transmission Categoryc
Male-to-male sexual contact 230 225 222 214 231
Injection drug use 38 37 43 36 25
Male-to-male sexual contact and injection drug use 8 9 12 11 9
Heterosexual contactd 110 112 128 101 86
Othere 2 2 3 2 1
Region of residencef
Northeast 96 7.4 85 6.3 79 5.6 69 4.9 64 4.5
Midwest 38 2.4 41 2.5 45 2.6 49 2.8 48 2.7
South 182 6.6 194 6.8 201 6.7 194 6.6 168 5.6
West 72 4.4 65 3.8 83 4.6 53 2.9 72 3.9
Subtotal, male adult 388 5.4 385 5.1 408 5.1 365 4.6 352 4.4
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 1 2.0 1 1.9 1 1.8 0 0.0
Asian 1 0.3 5 1.3 4 0.9 3 0.7 5 1.1
Black/African American 103 12.6 104 11.9 99 10.6 115 12.0 83 8.4
Hispanic/Latinob 14 2.1 22 3.0 27 3.5 18 2.2 25 3.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 14 0.2 17 0.3 17 0.3 12 0.2 16 0.2
Multiple races 3 4.6 3 4.4 6 8.2 3 4.0 8 10.2
Transmission Categoryc
Injection drug use 21 18 20 16 16
Heterosexual contactd 113 133 134 136 120
Othere 1 1 0 0 1
Region of residencef
Northeast 40 2.7 30 1.9 36 2.2 28 1.8 28 1.7
Midwest 15 0.9 13 0.7 13 0.7 13 0.7 12 0.6
South 66 2.1 85 2.6 91 2.7 97 2.9 69 2.0
West 14 0.8 24 1.3 14 0.7 14 0.7 28 1.4
Subtotal, female adult 135 1.7 152 1.8 154 1.7 152 1.7 137 1.5
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0.0 1 1.0 2 2.0 3 2.9 2 1.9
Asian 12 1.8 12 1.7 13 1.7 9 1.1 13 1.6
Black/African American 256 17.7 242 15.7 244 14.8 243 14.3 206 11.7
Hispanic/Latinob 70 5.6 89 6.6 86 6.0 92 6.2 85 5.4
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 1 5.1 0 0.0 1 4.6
White 174 1.5 172 1.4 204 1.6 161 1.3 165 1.3
Multiple races 11 9.1 21 16.2 12 8.7 9 6.4 17 11.5
Region of residencef
Northeast 136 4.9 115 4.0 115 3.8 97 3.2 92 3.0
Midwest 53 1.6 54 1.6 58 1.6 62 1.7 60 1.6
South 248 4.3 279 4.6 292 4.6 291 4.6 237 3.7
West 86 2.5 89 2.5 97 2.6 67 1.8 100 2.6
Total 523 3.4 537 3.3 562 3.3 517 3.1 489 2.9

70–74

Table 4a. Diagnoses of HIV infection among adults aged 70-74 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 7074 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 1 3.6 0 0.0 1 3.3 1 3.0 1 2.8
Asian 3 1.5 1 0.5 7 3.1 5 2.0 3 1.1
Black/African American 50 12.2 52 12.2 52 11.7 56 11.7 61 12.0
Hispanic/Latinob 21 5.6 28 7.0 23 5.4 22 4.7 34 6.8
Native Hawaiian/other Pacific Islander 1 19.3 0 0.0 1 16.4 1 14.8 0 0.0
White 61 1.5 70 1.7 54 1.3 64 1.4 75 1.5
Multiple races 6 16.3 3 7.7 4 9.7 3 6.6 3 6.2
Transmission Categoryc
Male-to-male sexual contact 77 86 78 86 106
Injection drug use 13 11 12 14 15
Male-to-male sexual contact and injection drug use 1 2 5 2 1
Heterosexual contactd 51 53 45 48 54
Othere 2 2 2 2 2
Region of residencef
Northeast 31 3.4 29 3.1 29 3.0 22 2.1 27 2.5
Midwest 15 1.4 17 1.5 9 0.8 14 1.1 16 1.2
South 73 3.7 76 3.7 81 3.8 71 3.1 98 4.1
West 24 2.1 32 2.7 23 1.9 45 3.3 36 2.5
Subtotal, male adult 143 2.8 154 2.9 142 2.6 152 2.6 177 2.8
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 1 0.4 2 0.7 2 0.6
Black/African American 27 4.7 27 4.5 26 4.2 43 6.5 43 6.2
Hispanic/Latinob 10 2.1 6 1.2 9 1.7 13 2.2 15 2.4
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 4 0.1 8 0.2 8 0.2 14 0.3 10 0.2
Multiple races 2 4.5 2 4.3 2 4.1 1 1.9 2 3.5
Transmission Categoryc
Injection drug use 8 5 7 8 8
Heterosexual contactd 35 38 39 65 64
Othere 1 0 0 1 0
Region of residencef
Northeast 18 1.6 13 1.2 13 1.1 18 1.4 20 1.6
Midwest 2 0.2 6 0.5 0 0.0 6 0.4 5 0.3
South 19 0.8 20 0.8 24 1.0 44 1.6 40 1.4
West 4 0.3 4 0.3 9 0.6 5 0.3 7 0.4
Subtotal, female adult 43 0.7 43 0.7 46 0.7 73 1.1 72 1.0
Both sexes
Race/Ethnicity
American Indian/Alaska Native 1 1.7 0 0.0 1 1.5 1 1.4 1 1.3
Asian 3 0.7 1 0.2 8 1.6 7 1.3 5 0.8
Black/African American 77 7.8 79 7.7 78 7.4 99 8.7 104 8.6
Hispanic/Latinob 31 3.6 34 3.7 32 3.3 35 3.4 49 4.4
Native Hawaiian/other Pacific Islander 1 9.3 0 0.0 1 7.9 1 7.2 0 0.0
White 65 0.8 78 0.9 62 0.7 78 0.8 85 0.8
Multiple races 8 9.9 5 5.9 6 6.7 4 4.0 5 4.7
Region of residencef
Northeast 49 2.4 42 2.0 42 2.0 40 1.7 47 2.0
Midwest 17 0.7 23 1.0 9 0.4 20 0.7 21 0.8
South 92 2.2 96 2.2 105 2.3 115 2.3 138 2.6
West 28 1.2 36 1.4 32 1.2 50 1.7 43 1.4
Total 186 1.7 197 1.7 188 1.6 225 1.8 249 1.9

75–79

Table 4a. Diagnoses of HIV infection among adults aged 75-79 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 7579 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 1 5.2 0 0.0 0 0.0
Asian 0 0.0 1 0.7 3 1.9 0 0.0 4 2.2
Black/African American 24 8.9 26 9.3 16 5.5 17 5.6 28 8.8
Hispanic/Latinob 7 2.7 11 4.1 9 3.2 15 5.1 12 3.8
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 37 1.3 23 0.8 22 0.7 20 0.7 21 0.6
Multiple races 3 12.7 3 12.0 1 3.8 1 3.5 0 0.0
Transmission Categoryc
Male-to-male sexual contact 43 28 31 29 34
Injection drug use 7 7 5 5 6
Male-to-male sexual contact and injection drug use 0 1 1 1 1
Heterosexual contactd 20 28 14 16 24
Othere 1 1 1 2 1
Region of residencef
Northeast 22 3.5 14 2.2 11 1.7 11 1.6 12 1.7
Midwest 4 0.5 4 0.5 2 0.3 5 0.6 9 1.0
South 32 2.4 33 2.4 22 1.5 25 1.7 29 1.8
West 13 1.7 13 1.6 17 2.0 12 1.4 15 1.6
Subtotal, male adult 71 2.0 64 1.8 52 1.4 53 1.4 65 1.6
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Black/African American 7 1.7 12 2.8 6 1.4 22 4.8 14 2.9
Hispanic/Latinob 5 1.4 4 1.1 6 1.6 8 2.0 10 2.3
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 3 0.1 2 0.1 3 0.1 4 0.1 3 0.1
Multiple races 0 0.0 0 0.0 1 3.0 1 2.9 1 2.7
Transmission Categoryc
Injection drug use 2 2 1 4 2
Heterosexual contactd 13 16 15 31 25
Othere 0 0 0 1 0
Region of residencef
Northeast 3 0.4 9 1.1 4 0.5 11 1.2 6 0.6
Midwest 1 0.1 1 0.1 0 0.0 1 0.1 2 0.2
South 9 0.5 7 0.4 11 0.6 20 1.1 15 0.8
West 2 0.2 1 0.1 1 0.1 3 0.3 5 0.4
Subtotal, female adult 15 0.3 18 0.4 16 0.3 35 0.7 28 0.5
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 1 2.3 0 0.0 0 0.0
Asian 0 0.0 1 0.3 3 0.8 0 0.0 4 1.0
Black/African American 31 4.5 38 5.4 22 3.0 39 5.1 42 5.3
Hispanic/Latinob 12 2.0 15 2.3 15 2.2 23 3.3 22 3.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 40 0.6 25 0.4 25 0.4 24 0.4 24 0.3
Multiple races 3 5.6 3 5.3 2 3.4 2 3.2 1 1.5
Region of residencef
Northeast 25 1.7 23 1.6 15 1.0 22 1.4 18 1.1
Midwest 5 0.3 5 0.3 2 0.1 6 0.3 11 0.6
South 41 1.4 40 1.3 33 1.0 45 1.3 44 1.2
West 15 0.9 14 0.8 18 1.0 15 0.8 20 1.0
Total 86 1.1 82 1.0 68 0.8 88 1.0 93 1.0

80–84

Table 4a. Diagnoses of HIV infection among adults aged 80-84 years, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 8084 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 1 1.1 1 1.1 0 0.0 0 0.0 2 1.7
Black/African American 15 9.2 4 2.4 8 4.5 9 4.9 11 5.8
Hispanic/Latinob 5 3.0 4 2.3 2 1.1 4 2.1 4 2.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 3 0.2 7 0.4 7 0.4 12 0.6 7 0.3
Multiple races 1 6.9 0 0.0 0 0.0 0 0.0 0 0.0
Transmission Categoryc
Male-to-male sexual contact 8 7 8 10 8
Injection drug use 3 1 1 3 3
Male-to-male sexual contact and injection drug use 0 0 0 0 1
Heterosexual contactd 14 8 7 12 12
Othere 0 0 1 1 0
Region of residencef
Northeast 7 1.5 5 1.1 5 1.1 7 1.5 5 1.1
Midwest 0 0.0 0 0.0 1 0.2 3 0.6 1 0.2
South 17 1.9 8 0.9 9 1.0 12 1.3 13 1.3
West 1 0.2 3 0.6 2 0.4 3 0.5 5 0.9
Subtotal, male adult 25 1.1 16 0.7 17 0.7 25 1.0 24 0.9
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Black/African American 2 0.7 7 2.3 5 1.6 6 1.9 6 1.8
Hispanic/Latinob 1 0.4 1 0.4 2 0.7 2 0.7 1 0.3
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 0 0.0 4 0.2 2 0.1 0 0.0 2 0.1
Multiple races 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Transmission Categoryc
Injection drug use 1 2 0 1 1
Heterosexual contactd 2 9 9 7 7
Othere 0 1 0 0 1
Region of residencef
Northeast 2 0.3 3 0.4 2 0.3 2 0.3 2 0.3
Midwest 0 0.0 1 0.1 2 0.3 0 0.0 1 0.1
South 0 0.0 7 0.6 5 0.4 6 0.5 4 0.3
West 1 0.1 1 0.1 0 0.0 0 0.0 2 0.3
Subtotal, female adult 3 0.1 12 0.4 9 0.3 8 0.2 9 0.3
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 1 0.5 1 0.4 0 0.0 0 0.0 2 0.7
Black/African American 17 3.7 11 2.4 13 2.7 15 3.0 17 3.3
Hispanic/Latinob 6 1.4 5 1.2 4 0.9 6 1.3 5 1.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 3 0.1 11 0.2 9 0.2 12 0.3 9 0.2
Multiple races 1 2.8 0 0.0 0 0.0 0 0.0 0 0.0
Region of residencef
Northeast 9 0.8 8 0.7 7 0.6 9 0.8 7 0.6
Midwest 0 0.0 1 0.1 3 0.2 3 0.2 2 0.2
South 17 0.8 15 0.7 14 0.6 18 0.8 17 0.7
West 2 0.2 4 0.3 2 0.2 3 0.2 7 0.5
Total 28 0.5 28 0.5 26 0.4 33 0.6 33 0.5

85+

Table 4a. Diagnoses of HIV infection among adults aged 85 years and older, by sex at birth, and selected characteristics, 2014-2018—United States
Aged 85+ Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Black/African American 2 1.5 2 1.5 3 2.1 4 2.8 4 2.6
Hispanic/Latinob 0 0.0 2 1.3 1 0.6 1 0.6 0 0.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 1 0.1 2 0.1 0 0.0 0 0.0 5 0.3
Multiple races 0 0.0 0 0.0 0 0.0 0 0.0 1 6.7
Transmission Categoryc
Male-to-male sexual contact 1 3 1 0 3
Injection drug use 0 2 1 1 2
Male-to-male sexual contact and injection drug use 0 0 0 0 0
Heterosexual contactd 1 1 2 4 4
Othere 0 1 0 0 1
Region of residencef
Northeast 1 0.2 1 0.2 2 0.4 2 0.4 4 0.9
Midwest 0 0.0 1 0.2 0 0.0 0 0.0 1 0.2
South 2 0.3 2 0.3 2 0.3 3 0.4 3 0.4
West 0 0.0 2 0.4 0 0.0 0 0.0 2 0.4
Subtotal, male adult 3 0.1 6 0.3 4 0.2 5 0.2 10 0.4
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Black/African American 4 1.3 0 0.0 3 0.9 3 0.9 2 0.6
Hispanic/Latinob 0 0.0 0 0.0 1 0.4 0 0.0 0 0.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 1 0.0 0 0.0 2 0.1 0 0.0 2 0.1
Multiple races 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Transmission Categoryc
Injection drug use 1 0 2 0 1
Heterosexual contactd 4 0 4 3 3
Othere 0 0 0 0 0
Region of residencef
Northeast 1 0.1 0 0.0 3 0.3 2 0.2 0 0.0
Midwest 1 0.1 0 0.0 0 0.0 0 0.0 1 0.1
South 3 0.2 0 0.0 2 0.1 1 0.1 3 0.2
West 0 0.0 0 0.0 1 0.1 0 0.0 0 0.0
Subtotal, female adult 5 0.1 0 0.0 6 0.1 3 0.1 4 0.1
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Asian 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Black/African American 6 1.4 2 0.4 6 1.3 7 1.4 6 1.2
Hispanic/Latinob 0 0.0 2 0.5 2 0.4 1 0.2 0 0.0
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
White 2 0.0 2 0.0 2 0.0 0 0.0 7 0.1
Multiple races 0 0.0 0 0.0 0 0.0 0 0.0 1 2.5
Region of residencef
Northeast 2 0.2 1 0.1 5 0.4 4 0.3 4 0.3
Midwest 1 0.1 1 0.1 0 0.0 0 0.0 2 0.1
South 5 0.2 2 0.1 4 0.2 4 0.2 6 0.3
West 0 0.0 2 0.1 1 0.1 0 0.0 2 0.1
Total 8 0.1 6 0.1 10 0.2 8 0.1 14 0.2

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
bHispanics/Latinos can be of any race.
cData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
eIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
fData are based on residence at time of diagnosis of HIV infection.

50–54

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 5054 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 13 8 7 11 13
Asian 43 45 40 39 30
Black/African American 673 703 668 611 590
Hispanic/Latinob 438 507 501 479 496
Native Hawaiian/other Pacific Islander 1 7 2 3 1
White 982 964 908 832 681
Multiple races 76 61 55 54 42
Transmission Categoryc
Male-to-male sexual contact 1,536 1,623 1,555 1,475 1,272
Injection drug use 165 172 162 139 153
Male-to-male sexual contact and injection drug use 92 92 78 81 80
Heterosexual contactd 431 408 384 332 346
Othere 1 1 1 1 2
Region of residencef
Northeast 424 20.7 391 19.3 351 17.8 322 16.7 299 15.9
Midwest 255 10.6 294 12.4 286 12.5 261 11.8 264 12.3
South 1,053 25.8 1,054 25.9 1,005 25.1 944 23.9 904 23.3
West 461 18.4 513 20.7 502 20.6 463 19.3 346 14.6
U.S. dependent areas 33 27.0 43 35.5 37 30.8 39 33.0 40 35.0
Subtotal, male adult 2,226 19.9 2,295 20.8 2,181 20.1 2,029 19.1 1,853 17.8
Female adult
Race/Ethnicity
American Indian/Alaska Native 5 4 5 7 3
Asian 8 8 10 15 9
Black/African American 415 432 439 385 374
Hispanic/Latinob 119 144 123 109 136
Native Hawaiian/other Pacific Islander 1 1 4 0 1
White 135 147 140 142 141
Multiple races 22 25 18 16 11
Transmission Categoryc
Injection drug use 101 103 119 99 95
Heterosexual contactd 603 657 619 575 579
Othere 1 0 1 0 1
Region of residencef
Northeast 149 6.9 173 8.1 161 7.7 150 7.4 136 6.9
Midwest 60 2.4 73 3.0 68 2.9 64 2.8 59 2.7
South 384 9.0 414 9.7 399 9.5 360 8.7 384 9.5
West 99 3.9 86 3.4 103 4.2 88 3.6 84 3.5
U.S. dependent areas 13 9.3 15 10.8 8 5.8 12 8.9 12 9.3
Subtotal, female adult 705 6.1 761 6.6 739 6.6 674 6.1 675 6.3
Both sexes
Race/Ethnicity
American Indian/Alaska Native 18 12 12 18 16
Asian 51 53 50 54 39
Black/African American 1,088 1,135 1,107 996 964
Hispanic/Latinob 557 651 624 588 632
Native Hawaiian/other Pacific Islander 2 8 6 3 2
White 1,117 1,111 1,048 974 822
Multiple races 98 86 73 70 53
Region of residencef
Northeast 573 13.6 564 13.6 512 12.6 472 11.9 435 11.3
Midwest 315 6.4 367 7.7 354 7.7 325 7.3 323 7.4
South 1,437 17.2 1,468 17.6 1,404 17.1 1,304 16.1 1,288 16.2
West 560 11.1 599 12.0 605 12.3 551 11.4 430 9.0
U.S. dependent areas 46 17.6 58 22.3 45 17.5 51 20.2 52 21.4
Total 2,931 12.9 3,056 13.6 2,920 13.2 2,703 12.5 2,528 12.0

55–59

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 5559 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 3 6 6 3 5
Asian 13 20 25 22 21
Black/African American 517 492 456 470 433
Hispanic/Latinob 244 269 260 258 287
Native Hawaiian/other Pacific Islander 0 3 1 1 5
White 549 538 569 550 552
Multiple races 40 40 42 31 16
Transmission Categoryc
Male-to-male sexual contact 862 857 904 878 891
Injection drug use 141 134 114 123 115
Male-to-male sexual contact and injection drug use 49 55 49 46 41
Heterosexual contactd 312 319 290 286 268
Othere 2 2 2 2 4
Region of residencef
Northeast 277 14.2 282 14.3 226 11.4 202 10.3 234 12.0
Midwest 162 6.9 155 6.6 187 7.9 171 7.3 148 6.4
South 637 16.8 650 16.9 628 16.1 652 16.6 644 16.2
West 259 11.0 260 10.9 282 11.7 287 11.9 273 11.3
U.S. dependent areas 31 27.0 21 18.3 36 31.4 23 20.2 20 17.7
Subtotal, male adult 1,366 13.0 1,368 12.8 1,359 12.6 1,335 12.4 1,319 12.2
Female adult
Race/Ethnicity
American Indian/Alaska Native 3 4 2 2 3
Asian 10 4 8 8 9
Black/African American 377 321 347 334 343
Hispanic/Latinob 102 80 97 86 91
Native Hawaiian/other Pacific Islander 1 1 0 1 1
White 96 115 112 132 102
Multiple races 13 22 19 13 9
Transmission Categoryc
Injection drug use 88 77 80 75 76
Heterosexual contactd 513 469 505 500 481
Othere 1 1 1 1 1
Region of residencef
Northeast 137 6.6 111 5.3 119 5.7 117 5.6 113 5.4
Midwest 62 2.5 59 2.4 65 2.6 75 3.1 57 2.4
South 320 7.8 303 7.3 305 7.3 294 7.0 300 7.1
West 69 2.8 63 2.5 82 3.3 79 3.1 80 3.2
U.S. dependent areas 14 10.5 11 8.2 14 10.6 11 8.4 8 6.1
Subtotal, female adult 602 5.4 547 4.8 585 5.1 576 5.0 558 4.9
Both sexes
Race/Ethnicity
American Indian/Alaska Native 6 10 8 5 8
Asian 23 24 33 30 30
Black/African American 894 813 803 804 776
Hispanic/Latinob 346 349 357 344 378
Native Hawaiian/other Pacific Islander 1 4 1 2 6
White 645 653 681 682 654
Multiple races 53 62 61 44 25
Region of residencef
Northeast 414 10.3 393 9.7 345 8.5 319 7.9 347 8.6
Midwest 224 4.7 214 4.4 252 5.2 246 5.1 205 4.3
South 957 12.2 953 11.9 933 11.5 946 11.6 944 11.5
West 328 6.8 323 6.6 364 7.4 366 7.4 353 7.1
U.S. dependent areas 45 18.1 32 12.9 50 20.2 34 13.9 28 11.5
Total 1,968 9.1 1,915 8.7 1,944 8.8 1,911 8.6 1,877 8.5

60–64

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 6064 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0 4 4 2
Asian 9 6 14 12 17
Black/African American 267 254 272 281 250
Hispanic/Latinob 137 111 136 134 136
Native Hawaiian/other Pacific Islander 2 0 0 0 1
White 292 321 303 313 314
Multiple races 16 22 25 20 12
Transmission Categoryc
Male-to-male sexual contact 438 429 439 456 471
Injection drug use 86 67 72 71 68
Male-to-male sexual contact and injection drug use 22 21 27 26 19
Heterosexual contactd 176 196 213 209 173
Othere 2 3 2 3 2
Region of residencef
Northeast 135 8.3 119 7.1 129 7.6 130 7.5 129 7.3
Midwest 79 4.0 82 4.0 95 4.6 82 3.9 87 4.0
South 348 10.8 364 11.0 363 10.7 385 11.0 345 9.6
West 138 6.8 135 6.5 149 7.0 152 7.0 156 7.1
U.S. dependent areas 23 22.1 14 13.5 18 17.2 15 14.2 15 14.2
Subtotal, male adult 723 8.1 714 7.8 754 8.0 764 7.9 732 7.4
Female adult
Race/Ethnicity
American Indian/Alaska Native 1 1 2 2 1
Asian 6 8 4 7 5
Black/African American 174 202 217 224 204
Hispanic/Latinob 47 39 54 52 58
Native Hawaiian/other Pacific Islander 1 0 0 0 0
White 33 44 70 51 49
Multiple races 11 6 5 3 9
Transmission Categoryc
Injection drug use 37 43 50 44 46
Heterosexual contactd 236 257 301 294 279
Othere 1 1 1 1 1
Region of residencef
Northeast 46 2.6 79 4.3 72 3.9 77 4.1 74 3.8
Midwest 20 0.9 28 1.3 40 1.8 30 1.3 24 1.0
South 159 4.4 154 4.2 197 5.2 187 4.8 176 4.4
West 44 2.0 38 1.7 36 1.6 40 1.7 48 2.0
U.S. dependent areas 4 3.2 1 0.8 7 5.6 5 4.0 4 3.2
Subtotal, female adult 273 2.8 300 3.0 352 3.4 339 3.2 326 3.0
Both sexes
Race/Ethnicity
American Indian/Alaska Native 1 1 6 6 3
Asian 15 14 18 19 22
Black/African American 441 456 489 505 454
Hispanic/Latinob 184 150 190 186 194
Native Hawaiian/other Pacific Islander 3 0 0 0 1
White 325 365 373 364 363
Multiple races 27 28 30 23 21
Region of residencef
Northeast 181 5.3 198 5.7 201 5.6 207 5.7 203 5.5
Midwest 99 2.4 110 2.6 135 3.1 112 2.6 111 2.5
South 507 7.4 518 7.4 560 7.8 572 7.7 521 6.9
West 182 4.3 173 4.0 185 4.2 192 4.2 204 4.4
U.S. dependent areas 27 11.9 15 6.6 25 10.9 20 8.7 19 8.3
Total 996 5.3 1,014 5.3 1,106 5.6 1,103 5.5 1,058 5.1

65–69

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 6569 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0 1 2 2
Asian 11 7 9 6 8
Black/African American 154 138 145 128 123
Hispanic/Latinob 65 79 74 81 70
Native Hawaiian/other Pacific Islander 0 0 1 0 1
White 160 155 187 149 149
Multiple races 8 18 6 6 9
Transmission Categoryc
Male-to-male sexual contact 233 228 223 217 233
Injection drug use 40 39 46 37 28
Male-to-male sexual contact and injection drug use 9 11 12 11 10
Heterosexual contactd 114 118 140 105 91
Othere 2 2 3 2 1
Region of residencef
Northeast 96 7.4 85 6.3 79 5.6 69 4.9 64 4.5
Midwest 38 2.4 41 2.5 45 2.6 49 2.8 48 2.7
South 182 6.6 194 6.8 201 6.7 194 6.6 168 5.6
West 72 4.4 65 3.8 83 4.6 53 2.9 72 3.9
U.S. dependent areas 10 10.3 12 12.2 15 15.5 7 7.4 10 10.7
Subtotal, male adult 398 5.4 397 5.2 423 5.3 372 4.6 362 4.5
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 1 1 1 0
Asian 1 5 4 3 5
Black/African American 103 105 99 115 83
Hispanic/Latinob 17 31 29 19 28
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 15 17 17 12 16
Multiple races 3 3 6 3 8
Transmission Categoryc
Injection drug use 22.0 18 20 16 16
Heterosexual contactd 116.0 143 135 137 123
Othere 1.0 1 0 0 1
Region of residencef
Northeast 40 2.7 30 1.9 36 2.2 28 1.8 28 1.7
Midwest 15 0.9 13 0.7 13 0.7 13 0.7 12 0.6
South 66 2.1 85 2.6 91 2.7 97 2.9 69 2.0
West 14 0.8 24 1.3 14 0.7 14 0.7 28 1.4
U.S. dependent areas 4 3.5 10 8.5 2 1.7 1 0.9 3 2.7
Subtotal, female adult 139 1.7 162 1.9 156 1.7 153 1.7 140 1.5
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 1 2 3 2
Asian 12 12 13 9 13
Black/African American 257 243 244 243 206
Hispanic/Latinob 82 110 103 100 98
Native Hawaiian/other Pacific Islander 0 0 1 0 1
White 175 172 204 161 165
Multiple races 11 21 12 9 17
Region of residencef
Northeast 136 4.9 115 4.0 115 3.8 97 3.2 92 3.0
Midwest 53 1.6 54 1.6 58 1.6 62 1.7 60 1.6
South 248 4.3 279 4.6 292 4.6 291 4.6 237 3.7
West 86 2.5 89 2.5 97 2.6 67 1.8 100 2.6
U.S. dependent areas 14 6.6 22 10.2 17 8.0 8 3.8 13 6.3
Total 537 3.5 559 3.4 579 3.4 525 3.1 502 2.9

70–74

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 7074 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 1 0 1 1 1
Asian 3 1 7 5 3
Black/African American 50 52 52 56 61
Hispanic/Latinob 26 34 26 25 38
Native Hawaiian/other Pacific Islander 1 0 1 1 0
White 61 70 54 64 75
Multiple races 6 3 4 3 3
Transmission Categoryc
Male-to-male sexual contact 78 90 79 87 107
Injection drug use 13 11 13 15 15
Male-to-male sexual contact and injection drug use 1 2 5 2 1
Heterosexual contactd 54 55 46 49 57
Othere 2 2 2 2 2
Region of residencef
Northeast 31 3.4 29 3.1 29 3.0 22 2.1 27 2.5
Midwest 15 1.4 17 1.5 9 0.8 14 1.1 16 1.2
South 73 3.7 76 3.7 81 3.8 71 3.1 98 4.1
West 24 2.1 32 2.7 23 1.9 45 3.3 36 2.5
U.S. dependent areas 5 6.8 6 7.9 3 3.8 3 3.7 4 4.8
Subtotal, male adult 148 2.9 160 3.0 145 2.6 155 2.6 181 2.9
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 1 2 2
Black/African American 27 28 26 43 43
Hispanic/Latinob 14 6 9 16 17
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 4 8 8 14 10
Multiple races 2 2 2 1 2
Transmission Categoryc
Injection drug use 8 5 7 8 8
Heterosexual contactd 39 39 39 68 66
Othere 1 0 0 1 0
Region of residencef
Northeast 18 1.6 13 1.2 13 1.1 18 1.4 20 1.6
Midwest 2 0.2 6 0.5 0 0.0 6 0.4 5 0.3
South 19 0.8 20 0.8 24 1.0 44 1.6 40 1.4
West 4 0.3 4 0.3 9 0.6 5 0.3 7 0.4
U.S. dependent areas 4 4.5 1 1.1 0 0.0 3 3.0 2 2.0
Subtotal, female adult 47 0.8 44 0.7 46 0.7 76 1.1 74 1.0
Both sexes
Race/Ethnicity
American Indian/Alaska Native 1 0 1 1 1
Asian 3 1 8 7 5
Black/African American 77 80 78 99 104
Hispanic/Latinob 40 40 35 41 55
Native Hawaiian/other Pacific Islander 1 0 1 1 0
White 65 78 62 78 85
Multiple races 8 5 6 4 5
Region of residencef
Northeast 49 2.4 42 2.0 42 2.0 40 1.7 47 2.0
Midwest 17 0.7 23 1.0 9 0.4 20 0.7 21 0.8
South 92 2.2 96 2.2 105 2.3 115 2.3 138 2.6
West 28 1.2 36 1.4 32 1.2 50 1.7 43 1.4
U.S. dependent areas 9 5.5 7 4.2 3 1.7 6 3.3 6 3.2
Total 195 1.7 204 1.8 191 1.6 231 1.8 255 1.9

75–79

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 7579 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0 1 0 0
Asian 0 1 3 0 4
Black/African American 24 26 16 17 28
Hispanic/Latinob 9 13 11 19 13
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 37 23 22 20 21
Multiple races 3 3 1 1 0
Transmission Categoryc
Male-to-male sexual contact 44 28 31 29 34
Injection drug use 7 7 5 8 6
Male-to-male sexual contact and injection drug use 0 1 1 1 1
Heterosexual contactd 21 30 16 18 25
Othere 1 1 1 2 1
Region of residencef
Northeast 22 3.5 14 2.2 11 1.7 11 1.6 12 1.7
Midwest 4 0.5 4 0.5 2 0.3 5 0.6 9 1.0
South 32 2.4 33 2.4 22 1.5 25 1.7 29 1.8
West 13 1.7 13 1.6 17 2.0 12 1.4 15 1.6
U.S. dependent areas 2 3.8 2 3.7 2 3.6 4 7.0 1 1.7
Subtotal, male adult 73 2.1 66 1.8 54 1.4 57 1.4 66 1.6
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 0 0 0
Black/African American 7 12 6 22 14
Hispanic/Latinob 5 4 6 8 11
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 3 2 3 4 3
Multiple races 0 0 1 1 1
Transmission Categoryc
Injection drug use 2 2 1 4 2
Heterosexual contactd 13 16 15 31 26
Othere 0 0 0 1 0
Region of residencef
Northeast 3 0.4 9 1.1 4 0.5 11 1.2 6 0.6
Midwest 1 0.1 1 0.1 0 0.0 1 0.1 2 0.2
South 9 0.5 7 0.4 11 0.6 20 1.1 15 0.8
West 2 0.2 1 0.1 1 0.1 3 0.3 5 0.4
U.S. dependent areas 0 0.0 0 0.0 0 0.0 0 0.0 1 1.3
Subtotal, female adult 15 0.3 18 0.4 16 0.3 35 0.7 29 0.6
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0 1 0 0
Asian 0 1 3 0 4
Black/African American 31 38 22 39 42
Hispanic/Latinob 14 17 17 27 24
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 40 25 25 24 24
Multiple races 3 3 2 2 1
Region of residencef
Northeast 25 1.7 23 1.6 15 1.0 22 1.4 18 1.1
Midwest 5 0.3 5 0.3 2 0.1 6 0.3 11 0.6
South 41 1.4 40 1.3 33 1.0 45 1.3 44 1.2
West 15 0.9 14 0.8 18 1.0 15 0.8 20 1.0
U.S. dependent areas 2 1.7 2 1.6 2 1.6 4 3.1 2 1.5
Total 88 1.1 84 1.0 70 0.8 92 1.0 95 1.0

80–84

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 8084 Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 1 1 0 0 2
Black/African American 15 4 8 9 11
Hispanic/Latinob 5 4 3 6 4
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 3 7 7 12 7
Multiple races 1 0 0 0 0
Transmission Categoryc
Male-to-male sexual contact 8 7 8 10 8
Injection drug use 3 1 1 3 3
Male-to-male sexual contact and injection drug use 0 0 0 0 1
Heterosexual contactd 14 8 8 14 12
Othere 0 0 1 1 0
Region of residencef
Northeast 7 1.5 5 1.1 5 1.1 7 1.5 5 1.1
Midwest 0 0.0 0 0.0 1 0.2 3 0.6 1 0.2
South 17 1.9 8 0.9 9 1.0 12 1.3 13 1.3
West 1 0.2 3 0.6 2 0.4 3 0.5 5 0.9
U.S. dependent areas 0 0.0 0 0.0 1 2.8 2 5.4 0 0.0
Subtotal, male adult 25 1.0 16 0.7 18 0.7 27 1.1 24 0.9
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 0 0 0
Black/African American 2 7 5 6 6
Hispanic/Latinob 1 1 2 2 1
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 0 4 2 0 2
Multiple races 0 0 0 0 0
Transmission Categoryc
Injection drug use 1 2 0 1 1
Heterosexual contactd 2 9 9 7 7
Othere 0 1 0 0 1
Region of residencef
Northeast 2 0.3 3 0.4 2 0.3 2 0.3 2 0.3
Midwest 0 0.0 1 0.1 2 0.3 0 0.0 1 0.1
South 0 0.0 7 0.6 5 0.4 6 0.5 4 0.3
West 1 0.1 1 0.1 0 0.0 0 0.0 2 0.3
U.S. dependent areas 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Subtotal, female adult 3 0.1 12 0.3 9 0.3 8 0.2 9 0.3
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 1 1 0 0 2
Black/African American 17 11 13 15 17
Hispanic/Latinob 6 5 5 8 5
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 3 11 9 12 9
Multiple races 1 0 0 0 0
Region of residencef
Northeast 9 0.8 8 0.7 7 0.6 9 0.8 7 0.6
Midwest 0 0.0 1 0.1 3 0.2 3 0.2 2 0.2
South 17 0.8 15 0.7 14 0.6 18 0.8 17 0.7
West 2 0.2 4 0.3 2 0.2 3 0.2 7 0.5
U.S. dependent areas 0 0.0 0 0.0 1 1.2 2 2.2 0 0.0
Total 28 0.5 28 0.5 27 0.5 35 0.6 33 0.5

85+

Table 4b. Diagnoses of HIV infection among adults aged 50 years and older, by 5-year age group, sex at birth, and selected characteristics, 2014-2018—United States and 6 dependent areas
Aged 85+ Years of Age at Diagnosis
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 0 0 0
Black/African American 2 2 3 4 4
Hispanic/Latinob 2 2 1 2 1
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 1 2 0 0 5
Multiple races 0 0 0 0 1
Transmission Categoryc
Male-to-male sexual contact 1 3 1 0 3
Injection drug use 0 2 1 1 2
Male-to-male sexual contact and injection drug use 0 0 0 0 0
Heterosexual contactd 3 1 2 4 5
Othere 0 1 0 0 1
Region of residencef
Northeast 1 0.2 1 0.2 2 0.4 2 0.4 4 0.9
Midwest 0 0.0 1 0.2 0 0.0 0 0.0 1 0.2
South 2 0.3 2 0.3 2 0.3 3 0.4 3 0.4
West 0 0.0 2 0.4 0 0.0 0 0.0 2 0.4
U.S. dependent areas 2 7.1 0 0.0 0 0.0 1 3.1 1 3.0
Subtotal, male adult 5 0.2 6 0.3 4 0.2 6 0.3 11 0.5
Female adult
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 0 0 0
Black/African American 4 0 3 3 2
Hispanic/Latinob 0 0 2 0 0
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 1 0 2 0 2
Multiple races 0 0 0 0 0
Transmission Categoryc
Injection drug use 1 0 2 0 1
Heterosexual contactd 4 0 5 3 3
Othere 0 0 0 0 0
Region of residencef
Northeast 1 0.1 0 0.0 3 0.3 2 0.2 0 0.0
Midwest 1 0.1 0 0.0 0 0.0 0 0.0 1 0.1
South 3 0.2 0 0.0 2 0.1 1 0.1 3 0.2
West 0 0.0 0 0.0 1 0.1 0 0.0 0 0.0
U.S. dependent areas 0 0.0 0 0.0 1 1.9 0 0.0 0 0.0
Subtotal, female adult 5 0.1 0 0.0 7 0.2 3 0.1 4 0.1
Both sexes
Race/Ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asian 0 0 0 0 0
Black/African American 6 2 6 7 6
Hispanic/Latinob 2 2 3 2 1
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 2 2 2 0 7
Multiple races 0 0 0 0 1
Region of residencef
Northeast 2 0.2 1 0.1 5 0.4 4 0.3 4 0.3
Midwest 1 0.1 1 0.1 0 0.0 0 0.0 2 0.1
South 5 0.2 2 0.1 4 0.2 4 0.2 6 0.3
West 0 0.0 2 0.1 1 0.1 0 0.0 2 0.1
U.S. dependent areas 2 2.6 0 0.0 1 1.2 1 1.2 1 1.1
Total 10 0.2 6 0.1 11 0.2 9 0.1 15 0.2

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
bHispanics/Latinos can be of any race.
cData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
eIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
fData are based on residence at time of diagnosis of HIV infection.

American Indian/Alaska Native

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
American Indian/Alaska Native
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 9 8 10 12 13
Injection drug use 3 2 4 4 3
Male-to-male sexual contact and injection drug use 2 0 2 1 1
Heterosexual contactc 1 3 2 1 3
Otherd 0 0 0 0 0
Region of residencee
Northeast 1 7.9 1 7.8 0 0.0 0 0.0 1 7.7
Midwest 1 2.9 2 5.7 3 8.5 3 8.4 4 11.2
South 8 11.0 4 5.4 2 2.7 6 8.1 5 6.8
West 6 7.0 7 8.1 12 13.8 9 10.3 10 11.4
Subtotal, male aged 50–64 years 16 7.8 14 6.7 17 8.1 18 8.6 20 9.5
Female adult
Transmission Categoryb
Injection drug use 1 3 5 2 2
Heterosexual contactc 8 6 4 9 5
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Midwest 1 2.7 1 2.6 0 0.0 1 2.6 0 0.0
South 2 2.5 5 6.2 3 3.7 0 0.0 4 4.9
West 6 6.2 3 3.0 6 6.0 10 10.0 3 3.0
Subtotal, female aged 50–64 years 9 4.0 9 3.9 9 3.9 11 4.7 7 3.0
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 1 0 1 1 3
Injection drug use 0 0 0 1 0
Male-to-male sexual contact and injection drug use 0 0 0 1 0
Heterosexual contactc 0 0 2 0 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 1 12.7 0 0.0
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 1 2.2 1 2.1 2 4.0
West 1 2.3 0 0.0 2 4.2 1 2.0 1 1.9
Subtotal, male aged ≥65 years 1 1.0 0 0.0 3 2.6 3 2.4 3 2.3
Female adult
Transmission Categoryb
Injection drug use 0 0 0 1 0
Heterosexual contactc 0 1 1 0 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 0 0.0 1 1.8 0 0.0
West 0 0.0 1 1.7 1 1.7 0 0.0 0 0.0
Subtotal, female aged ≥65 years 0 0.0 1 0.7 1 0.7 1 0.7 0 0.0
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 10 8 11 13 15
Injection drug use 3 2 4 5 3
Male-to-male sexual contact and injection drug use 2 0 2 2 1
Heterosexual contactc 1 3 3 1 4
Otherd 0 0 0 0 0
Region of residencee
Northeast 1 5.2 1 5.0 0 0.0 1 4.8 1 4.7
Midwest 1 2.0 2 3.9 3 5.8 3 5.6 4 7.3
South 8 7.1 4 3.5 3 2.5 7 5.8 7 5.7
West 7 5.5 7 5.3 14 10.4 10 7.3 11 7.9
Subtotal, male ≥50 years of age 17 5.5 14 4.4 20 6.1 21 6.3 23 6.8
Female adult
Transmission Categoryb
Injection drug use 1 3 5 3 2
Heterosexual contactc 8 7 5 9 5
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Midwest 1 1.8 1 1.7 0 0.0 1 1.6 0 0.0
South 2 1.6 5 3.9 3 2.3 1 0.7 4 2.9
West 6 4.0 4 2.6 7 4.4 10 6.1 3 1.8
Subtotal, female ≥50 years of age  9 2.5 10 2.7 10 2.7 12 3.1 7 1.8
Total, ≥50 years of age at diagnosis 26 3.9 24 3.5 30 4.3 33 4.6 30 4.1

Asian

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
Asian
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 48 55 61 62 51
Injection drug use 2 4 4 2 3
Male-to-male sexual contact and injection drug use 3 1 1 0 1
Heterosexual contactc 11 11 12 9 13
Otherd 0 0 0 0 1
Region of residencee
Northeast 18 6.3 14 4.8 14 4.7 14 4.6 19 6.1
Midwest 3 2.3 8 5.9 13 9.3 3 2.1 5 3.3
South 11 3.9 14 4.7 18 5.8 14 4.3 14 4.1
West 32 5.0 35 5.4 34 5.1 42 6.2 30 4.3
Subtotal, male  aged 50–64 years 64 4.8 71 5.2 79 5.6 73 5.0 68 4.6
Female adult
Transmission Categoryb
Injection drug use 3 2 1 2 1
Heterosexual contactc 21 18 21 28 22
Otherd 0 0 0 1 0
Region of residencee
Northeast 1 0.3 5 1.5 5 1.5 6 1.8 11 3.1
Midwest 4 2.6 3 1.9 1 0.6 2 1.2 0 0.0
South 4 1.2 4 1.1 4 1.1 8 2.1 7 1.8
West 15 1.9 8 1.0 12 1.5 14 1.7 5 0.6
Subtotal, female adult aged 50–64 years 24 1.5 20 1.2 22 1.3 30 1.7 23 1.3
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 8 5 10 8 10
Injection drug use 1 1 1 0 1
Male-to-male sexual contact and injection drug use 0 0 1 0 0
Heterosexual contactc 6 4 6 2 6
Otherd 0 0 1 1 0
Region of residencee
Northeast 5 3.2 3 1.8 6 3.4 1 0.5 4 2.0
Midwest 2 2.8 0 0.0 3 3.6 2 2.3 0 0.0
South 1 0.7 1 0.6 3 1.7 4 2.1 4 2.0
West 7 1.7 6 1.3 7 1.5 4 0.8 9 1.7
Subtotal, male aged ≥65 years 15 1.9 10 1.2 19 2.1 11 1.1 17 1.7
Female adult
Transmission Categoryb
Injection drug use 0 0 0 0 0
Heterosexual contactc 1 4 5 5 7
Otherd 0 1 0 0 0
Region of residencee
Northeast 1 0.5 0 0.0 2 0.9 1 0.4 2 0.8
Midwest 0 0.0 0 0.0 1 0.9 1 0.9 0 0.0
South 0 0.0 2 0.9 0 0.0 2 0.8 2 0.7
West 0 0.0 3 0.5 2 0.3 1 0.1 3 0.4
Subtotal, female aged ≥65 years 1 0.1 5 0.4 5 0.4 5 0.4 7 0.5
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 56 60 72 70 61
Injection drug use 3 5 5 2 4
Male-to-male sexual contact and injection drug use 3 1 2 0 1
Heterosexual contactc 16 14 18 11 19
Otherd 1 1 1 1 1
Region of residencee
Northeast 23 5.2 17 3.7 20 4.2 15 3.1 23 4.5
Midwest 5 2.5 8 3.8 16 7.2 5 2.1 5 2.0
South 12 2.8 15 3.3 21 4.3 18 3.5 18 3.3
West 39 3.7 41 3.7 41 3.6 46 3.9 39 3.2
Subtotal, male ≥50 years of age  79 3.7 81 3.6 98 4.2 84 3.5 85 3.4
Female adult
Transmission Categoryb
Injection drug use 3 2 1 2 1
Heterosexual contactc 22 22 26 33 28
Otherd 0 1 0 1 1
Region of residencee
Northeast 2 0.4 5 1.0 7 1.3 7 1.2 13 2.2
Midwest 4 1.6 3 1.2 2 0.7 3 1.1 0 0.0
South 4 0.7 6 1.1 4 0.7 10 1.6 9 1.3
West 15 1.1 11 0.8 14 1.0 15 1.0 8 0.5
Subtotal, female ≥50 years of age  25 0.9 25 0.9 27 0.9 35 1.2 30 1.0
Total, ≥50 years of age at diagnosis 104 2.2 106 2.1 125 2.4 119 2.2 115 2.0

Black/African American

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
Black/African American
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 664 654 680 665 628
Injection drug use 177 158 143 136 129
Male-to-male sexual contact and injection drug use 47 32 30 41 33
Heterosexual contactc 560 604 538 518 478
Otherd 3 2 2 3 3
Region of residencee
Northeast 321 60.7 288 53.4 228 41.8 255 46.4 240 43.4
Midwest 152 26.9 169 29.7 155 27.1 174 30.4 178 31.1
South 856 45.1 871 45.0 862 44.0 796 40.3 735 37.0
West 122 37.6 121 36.7 149 44.6 137 40.6 118 34.7
Subtotal, male aged 50–64 years 1,451 43.7 1,449 43.0 1,394 40.9 1,362 39.7 1,271 36.8
Female adult
Transmission Categoryb
Injection drug use 118 102 119 95 97
Heterosexual contactc 844 852 884 847 824
Otherd 1 0 1 1 1
Region of residencee
Northeast 190 29.7 205 31.6 210 32.1 187 28.4 179 27.1
Midwest 90 13.6 93 14.0 103 15.5 100 15.1 87 13.1
South 616 27.3 591 25.7 614 26.3 583 24.7 574 24.2
West 67 20.8 66 20.2 76 23.0 73 21.9 81 24.1
Subtotal, female adult aged 50–64 years 963 24.8 955 24.2 1,003 25.2 943 23.5 921 22.8
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 79 81 68 69 80
Injection drug use 38 30 31 28 33
Male-to-male sexual contact and injection drug use 5 5 4 4 3
Heterosexual contactc 122 106 120 112 108
Otherd 1 1 1 1 2
Region of residencee
Northeast 68 25.5 50 18.0 49 17.0 47 15.8 38 12.4
Midwest 16 5.7 23 7.9 26 8.6 21 6.7 25 7.7
South 150 16.6 132 13.8 133 13.2 132 12.5 147 13.2
West 10 6.5 17 10.6 16 9.5 14 8.0 17 9.3
Subtotal, male aged ≥65 years 244 15.2 222 13.2 224 12.7 214 11.6 227 11.8
Female adult
Transmission Categoryb
Injection drug use 18 14 16 19 17
Heterosexual contactc 125 135 123 170 131
Otherd 1 0 0 0 0
Region of residencee
Northeast 43 9.8 29 6.4 19 4.1 40 8.4 30 6.1
Midwest 13 3.1 17 3.9 9 2.0 13 2.8 14 2.9
South 80 6.0 97 6.9 98 6.6 125 8.0 91 5.6
West 7 3.5 7 3.3 13 5.9 11 4.8 13 5.5
Subtotal, female aged ≥65 years 143 5.9 150 6.0 139 5.3 189 6.9 148 5.2
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 742 735 748 734 708
Injection drug use 215 188 174 164 162
Male-to-male sexual contact and injection drug use 52 36 34 45 36
Heterosexual contactc 682 710 658 629 586
Otherd 4 3 3 4 5
Region of residencee
Northeast 389 48.8 338 41.4 277 33.2 302 35.7 278 32.3
Midwest 168 19.9 192 22.3 181 20.7 195 22.0 203 22.6
South 1,006 35.9 1,003 34.7 995 33.5 928 30.6 882 28.5
West 132 27.7 138 28.1 165 32.9 151 29.5 135 25.8
Subtotal, male ≥50 years of age  1,695 34.4 1,671 33.0 1,618 31.2 1,576 29.8 1,498 27.8
Female adult
Transmission Categoryb
Injection drug use 136 116 135 114 114
Heterosexual contactc 968 988 1,006 1,017 955
Otherd 2 1 1 1 1
Region of residencee
Northeast 233 21.6 234 21.3 229 20.4 227 20.0 209 18.2
Midwest 103 9.5 110 10.0 112 10.0 113 10.0 101 8.8
South 696 19.3 688 18.5 712 18.6 708 18.1 665 16.6
West 74 14.1 73 13.6 89 16.2 84 14.9 94 16.4
Subtotal, female ≥50 years of age  1,106 17.6 1,105 17.1 1,142 17.3 1,132 16.8 1,069 15.5
Total, ≥50 years of age at diagnosis 2,801 25.0 2,776 24.1 2,760 23.4 2,708 22.5 2,567 20.9

Hispanic/Latino

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
Hispanic/Latinof
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 507 589 586 581 619
Injection drug use 75 71 75 73 77
Male-to-male sexual contact and injection drug use 22 19 28 25 24
Heterosexual contactc 136 133 120 116 128
Otherd 1 1 1 1 1
Region of residencee
Northeast 154 31.1 177 34.3 163 30.4 136 24.5 163 28.4
Midwest 40 14.5 51 17.7 43 14.3 41 13.0 42 12.8
South 349 27.6 349 26.1 347 24.7 364 24.8 406 26.4
West 197 14.5 235 16.6 256 17.4 255 16.7 238 15.0
Subtotal, male aged 50–64 years 740 21.8 812 22.8 809 21.8 796 20.6 849 21.1
Female adult
Transmission Categoryb
Injection drug use 37 26 37 28 31
Heterosexual contactc 203 210 208 192 230
Otherd 0 0 0 0 0
Region of residencee
Northeast 87 15.6 86 14.9 89 14.9 80 13.0 81 12.8
Midwest 10 3.8 10 3.7 11 3.9 10 3.4 12 3.9
South 81 6.2 95 6.9 97 6.7 88 5.8 118 7.5
West 62 4.4 45 3.1 48 3.2 42 2.7 50 3.1
Subtotal, female aged 50–64 years 240 6.8 236 6.4 245 6.4 220 5.5 261 6.3
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 55 58 52 72 69
Injection drug use 7 13 13 13 8
Male-to-male sexual contact and injection drug use 1 2 3 2 2
Heterosexual contactc 25 37 25 28 31
Otherd 1 1 1 1 1
Region of residencee
Northeast 22 9.8 36 15.2 19 7.6 22 8.3 21 7.5
Midwest 5 4.8 4 3.6 1 0.8 3 2.3 13 9.4
South 38 6.3 51 8.0 49 7.2 54 7.5 41 5.4
West 24 4.1 21 3.4 25 3.8 37 5.3 35 4.7
Subtotal, male aged ≥65 years 89 5.9 112 6.9 94 5.5 116 6.4 110 5.7
Female adult
Transmission Categoryb
Injection drug use 7 6 5 4 4
Heterosexual contactc 23 27 40 37 47
Otherd 0 0 0 0 0
Region of residencee
Northeast 13 4.0 15 4.4 22 6.1 13 3.5 17 4.3
Midwest 2 1.6 0 0.0 0 0.0 4 2.7 2 1.3
South 10 1.3 7 0.8 15 1.7 20 2.1 17 1.7
West 5 0.7 11 1.4 8 0.9 4 0.4 15 1.6
Subtotal, female aged ≥65 years 30 1.5 33 1.6 45 2.0 41 1.7 51 2.0
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 562 647 638 653 688
Injection drug use 81 84 88 86 85
Male-to-male sexual contact and injection drug use 23 21 31 27 26
Heterosexual contactc 162 170 144 144 159
Otherd 1 2 2 2 2
Region of residencee
Northeast 176 24.5 213 28.3 182 23.1 158 19.3 184 21.6
Midwest 45 11.8 55 13.7 44 10.4 44 9.9 55 11.8
South 387 20.8 400 20.3 396 19.0 418 19.1 447 19.4
West 221 11.4 256 12.5 281 13.1 292 13.1 273 11.7
Subtotal, male ≥50 years of age  829 16.9 924 17.9 903 16.6 912 16.1 959 16.1
Female adult
Transmission Categoryb
Injection drug use 43 32 42 32 35
Heterosexual contactc 227 237 247 228 277
Otherd 0 0 0 0 0
Region of residencee
Northeast 100 11.4 101 11.0 111 11.6 93 9.4 98 9.5
Midwest 12 3.1 10 2.5 11 2.6 14 3.1 14 3.0
South 91 4.3 102 4.6 112 4.8 108 4.4 135 5.2
West 67 3.1 56 2.5 56 2.4 46 1.9 65 2.5
Subtotal, female adult ≥50 years of age  270 4.9 269 4.6 290 4.8 261 4.1 312 4.7
Total, ≥50 years of age at diagnosis 1,099 10.5 1,193 10.9 1,193 10.4 1,173 9.8 1,271 10.1

Native Hawaiian/other Pacific Islander

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
Native Hawaiian/other Pacific Islander
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 1 7 2 1 6
Injection drug use 1 0 0 1 0
Male-to-male sexual contact and injection drug use 0 0 0 0 0
Heterosexual contactc 0 2 0 0 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 1 62.6 0 0.0 1 56.6 0 0.0 1 52.5
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 1 18.2 2 34.5 0 0.0 0 0.0 0 0.0
West 1 3.1 7 20.7 1 2.9 2 5.7 5 13.9
Subtotal, adult aged 50–64 years 3 7.2 9 20.8 2 4.5 2 4.4 6 12.8
Female adult
Transmission Categoryb
Injection drug use 0 0 2 0 0
Heterosexual contactc 3 2 2 1 2
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 1 47.3
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 1 15.2 0 0.0 1 13.9
West 3 8.9 2 5.8 3 8.4 1 2.7 0 0.0
Subtotal, female aged 50–64 years 3 6.9 2 4.4 4 8.6 1 2.1 2 4.1
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 1 0 1 0 1
Injection drug use 0 0 0 0 0
Male-to-male sexual contact and injection drug use 0 0 1 0 0
Heterosexual contactc 0 0 0 1 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 1 120.9 1 109.6
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 1 36.0 0 0.0 0 0.0
West 1 6.2 0 0.0 1 5.4 0 0.0 0 0.0
Subtotal, male aged ≥65 years 1 5.1 0 0.0 2 8.7 1 4.0 1 3.8
Female adult
Transmission Categoryb
Injection drug use 0 0 0 0 0
Heterosexual contactc 0 0 0 0 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
West 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Subtotal, female aged ≥65 years 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 2 7 3 1 7
Injection drug use 1 0 0 1 0
Male-to-male sexual contact and injection drug use 0 0 1 0 0
Heterosexual contactc 0 2 0 1 0
Otherd 0 0 0 0 0
Region of residencee
Northeast 1 43.8 0 0.0 1 39.4 1 37.4 2 71.0
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 1 12.8 2 24.1 1 11.4 0 0.0 0 0.0
West 2 4.1 7 13.7 2 3.8 2 3.6 5 8.8
Subtotal, male  ≥50 years of age  4 6.5 9 13.9 4 5.9 3 4.3 7 9.5
Female adult
Transmission Categoryb
Injection drug use 0 0 2 0 0
Heterosexual contactc 3 2 2 1 2
Otherd 0 0 0 0 0
Region of residencee
Northeast 0 0.0 0 0.0 0 0.0 0 0.0 1 30.1
Midwest 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
South 0 0.0 0 0.0 1 10.3 0 0.0 1 9.1
West 3 5.8 2 3.7 3 5.3 1 1.7 0 0.0
Subtotal, female adult ≥50 years of age  3 4.5 2 2.9 4 5.5 1 1.3 2 2.5
Total, ≥50 years of age at diagnosis 7 5.5 11 8.2 8 5.7 4 2.7 9 5.9

White

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
White
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 1,492 1,478 1,434 1,380 1,234
Injection drug use 100 107 96 95 106
Male-to-male sexual contact and injection drug use 83 108 85 76 76
Heterosexual contactc 146 125 163 142 127
Otherd 1 3 1 2 2
Region of residencee
Northeast 304 7.1 275 6.5 273 6.5 223 5.3 218 5.3
Midwest 290 5.1 290 5.1 334 5.9 283 5.1 263 4.8
South 757 10.1 778 10.4 716 9.6 752 10.1 702 9.5
West 471 10.9 478 11.1 457 10.7 437 10.4 362 8.7
Subtotal, male aged 50–64 years 1,822 8.4 1,821 8.4 1,780 8.2 1,695 7.9 1,545 7.3
Female adult
Transmission Categoryb
Injection drug use 54 77 73 80 79
Heterosexual contactc 209 228 247 242 211
Otherd 1 1 2 1 2
Region of residencee
Northeast 45 1.0 52 1.2 39 0.9 58 1.3 41 1.0
Midwest 33 0.6 48 0.8 52 0.9 54 0.9 40 0.7
South 135 1.7 149 1.9 158 2.0 150 1.9 146 1.9
West 51 1.2 57 1.3 73 1.7 62 1.4 65 1.5
Subtotal, female aged 50–64 years 264 1.2 306 1.4 322 1.4 324 1.5 292 1.3
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 207 192 200 184 210
Injection drug use 13 9 16 16 7
Male-to-male sexual contact and injection drug use 3 4 8 8 6
Heterosexual contactc 37 48 43 34 31
Otherd 3 3 3 3 2
Region of residencee
Northeast 56 1.8 39 1.3 48 1.5 36 1.1 42 1.3
Midwest 33 0.8 32 0.8 26 0.6 43 1.0 36 0.8
South 108 1.8 117 1.9 123 2.0 109 1.7 113 1.7
West 65 2.0 69 2.0 73 2.1 57 1.6 66 1.8
Subtotal, male aged ≥65 years 262 1.6 257 1.5 270 1.6 245 1.4 257 1.4
Female adult
Transmission Categoryb
Injection drug use 6 5 8 5 6
Heterosexual contactc 15 25 23 24 25
Otherd 1 1 1 1 2
Region of residencee
Northeast 5 0.1 9 0.2 13 0.3 5 0.1 5 0.1
Midwest 4 0.1 4 0.1 3 0.1 2 0.0 5 0.1
South 4 0.1 11 0.1 15 0.2 18 0.2 16 0.2
West 9 0.2 7 0.2 1 0.0 5 0.1 7 0.2
Subtotal, female aged ≥65 years 22 0.1 31 0.2 32 0.2 30 0.1 33 0.1
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 1,699 1,670 1,634 1,564 1,444
Injection drug use 113 117 112 111 113
Male-to-male sexual contact and injection drug use 85 113 93 85 82
Heterosexual contactc 183 173 206 175 158
Otherd 4 6 5 5 5
Region of residencee
Northeast 360 4.9 314 4.3 321 4.3 259 3.5 260 3.5
Midwest 323 3.4 322 3.3 360 3.7 326 3.3 299 3.0
South 865 6.5 895 6.6 839 6.1 861 6.2 815 5.8
West 536 7.1 547 7.1 530 6.8 494 6.3 428 5.4
Subtotal, male ≥50 years of age  2,084 5.5 2,078 5.4 2,050 5.3 1,940 5.0 1,802 4.6
Female adult
Transmission Categoryb
Injection drug use 61 82 81 85 86
Heterosexual contactc 224 253 270 267 236
Otherd 2 2 3 2 3
Region of residencee
Northeast 50 0.6 61 0.7 52 0.6 63 0.7 46 0.5
Midwest 37 0.3 52 0.5 55 0.5 56 0.5 45 0.4
South 139 0.9 160 1.0 173 1.1 168 1.1 162 1.0
West 60 0.7 64 0.8 74 0.9 67 0.8 72 0.8
Subtotal, female ≥50 years of age  286 0.7 337 0.8 354 0.8 354 0.8 325 0.7
Total, ≥50 years of age at diagnosis 2,370 2.9 2,415 3.0 2,404 2.9 2,294 2.8 2,127 2.6

Multiple Races

Table 5a. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States
Multiple Races
2014 2015 2016 2017 2018
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 89 84 81 73 46
Injection drug use 12 12 12 5 10
Male-to-male sexual contact and injection drug use 7 4 8 9 3
Heterosexual contactc 24 23 21 17 11
Otherd 0 1 1 0 0
Region of residencee
Northeast 37 92.3 37 89.7 27 64.0 26 60.6 20 45.9
Midwest 10 21.6 11 23.3 20 41.7 10 20.5 7 14.1
South 56 59.4 50 51.8 51 51.8 49 49.0 31 30.5
West 29 26.0 25 21.9 24 20.6 20 16.9 12 10.0
Subtotal, male  aged 50–64 years 132 45.1 123 41.1 122 40.0 105 33.9 70 22.2
Female adult
Transmission Categoryb
Injection drug use 11 13 10 7 7
Heterosexual contactc 35 41 32 25 22
Otherd 0 0 0 0 0
Region of residencee
Northeast 9 19.9 15 32.2 9 18.9 13 26.8 10 20.2
Midwest 4 7.9 5 9.7 6 11.4 2 3.7 1 1.8
South 25 23.7 27 24.9 24 21.6 12 10.5 10 8.6
West 8 6.6 6 4.8 3 2.4 5 3.9 8 6.1
Subtotal, female aged 50–64 years 46 14.3 53 16.0 42 12.4 32 9.3 29 8.3
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categoryb
Male-to-male sexual contact 10 13 8 5 10
Injection drug use 2 4 1 0 1
Male-to-male sexual contact and injection drug use 0 1 0 0 0
Heterosexual contactc 6 7 2 4 3
Otherd 0 0 0 0 0
Region of residencee
Northeast 6 32.3 6 30.7 4 19.5 3 13.9 6 26.3
Midwest 1 4.6 4 17.2 1 4.0 2 7.6 1 3.6
South 9 18.2 12 22.8 5 8.9 5 8.4 4 6.4
West 2 3.8 2 3.5 1 1.7 0 0.0 2 3.0
Subtotal, male  aged ≥65 years 18 12.6 24 15.7 11 6.8 10 5.8 13 7.2
Female adult
Transmission Categoryb
Injection drug use 2 1 1 0 2
Heterosexual contactc 3 4 8 5 9
Otherd 0 0 0 0 0
Region of residencee
Northeast 2 8.0 2 7.7 2 7.4 2 7.0 2 6.7
Midwest 0 0.0 0 0.0 2 6.5 0 0.0 0 0.0
South 3 4.8 2 3.0 5 7.1 2 2.7 5 6.4
West 0 0.0 1 1.5 0 0.0 1 1.3 4 4.9
Subtotal, female aged ≥65 years 5 2.8 5 2.6 9 4.5 5 2.4 11 4.9
Aged ≥50 years of age at diagnosis 
Male adult
Transmission Categoryb
Male-to-male sexual contact 99 97 89 79 55
Injection drug use 14 15 12 5 11
Male-to-male sexual contact and injection drug use 7 5 8 9 3
Heterosexual contactc 29 30 22 22 14
Otherd 0 1 1 0 0
Region of residencee
Northeast 43 73.3 43 70.7 31 49.4 29 44.9 26 39.2
Midwest 11 16.1 15 21.3 21 28.9 12 16.0 8 10.3
South 65 45.2 62 41.5 56 36.3 54 33.9 35 21.3
West 31 18.8 27 15.8 25 14.1 20 11.0 14 7.5
Subtotal, male ≥50 years of age  150 34.4 147 32.5 133 28.5 115 23.9 83 16.7
Female adult
Transmission Categoryb
Injection drug use 13 14 11 7 9
Heterosexual contactc 38 44 41 30 31
Otherd 0 0 0 0 0
Region of residencee
Northeast 11 15.7 17 23.4 11 14.7 15 19.5 12 15.1
Midwest 4 5.1 5 6.2 8 9.6 2 2.3 1 1.1
South 28 16.6 29 16.6 29 16.0 14 7.5 15 7.7
West 8 4.3 7 3.6 3 1.5 6 2.9 12 5.6
Subtotal, female adult ≥50 years of age  51 10.1 58 11.1 51 9.5 37 6.6 40 7.0
Total, ≥50 years of age at diagnosis 201 21.4 205 21.1 184 18.3 152 14.6 123 11.5

Note. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
bData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to the column subtotals and total.
cHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.
dIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
eData are based on residence at time of diagnosis of HIV infection.
fHispanics/Latinos can be of any race.

American Indian/Alaska Native

Table 5b. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States and 6 dependent areas
American Indian/Alaska Native
2014 2015 2016 2017 2018
No. No. No. No. No.
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 9 8 10 12 13
Injection drug use 3 2 4 4 3
Male-to-male sexual contact and injection drug use 2 0 2 1 1
Heterosexual contactb 1 3 2 1 3
Otherc 0 0 0 0 0
Region of residenced
Northeast 1 1 0 0 1
Midwest 1 2 3 3 4
South 8 4 2 6 5
West 6 7 12 9 10
U.S. dependent areas 0 0 0 0 0
Subtotal, male adult aged 50–64 years 16 14 17 18 20
Female adult
Transmission Categorya
Injection drug use 1 3 5 2 2
Heterosexual contactb 8 6 4 9 5
Otherc 0 0 0 0 0
Region of residenced
Northeast 0 0 0 0 0
Midwest 1 1 0 1 0
South 2 5 3 0 4
West 6 3 6 10 3
U.S. dependent areas 0 0 0 0 0
Subtotal, female aged 50–64 years 9 9 9 11 7
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 1 0 1 1 3
Injection drug use 0 0 0 1 0
Male-to-male sexual contact and injection drug use 0 0 0 1 0
Heterosexual contactb 0 0 2 0 0
Otherc 0 0 0 0 0
Region of residenced
Northeast 0 0 0 1 0
Midwest 0 0 0 0 0
South 0 0 1 1 2
West 1 0 2 1 1
U.S. dependent areas 0 0 0 0 0
Subtotal, male aged ≥65 years 1 0 3 3 3
Female adult
Transmission Categorya
Injection drug use 0 0 0 1 0
Heterosexual contactb 0 1 1 0 0
Otherc 0 0 0 0 0
Region of residenced
Northeast 0 0 0 0 0
Midwest 0 0 0 0 0
South 0 0 0 1 0
West 0 1 1 0 0
U.S. dependent areas 0 0 0 0 0
Subtotal, female aged ≥65 years 0 1 1 1 0
Aged ≥50 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 10 8 11 13 15
Injection drug use 3 2 4 5 3
Male-to-male sexual contact and injection drug use 2 0 2 2 1
Heterosexual contactb 1 3 3 1 4
Otherc 0 0 0 0 0
Region of residenced
Northeast 1 1 0 1 1
Midwest 1 2 3 3 4
South 8 4 3 7 7
West 7 7 14 10 11
U.S. dependent areas 0 0 0 0 0
Subtotal, male ≥50 years of age 17 14 20 21 23
Female adult
Transmission Categorya
Injection drug use 1 3 5 3 2
Heterosexual contactb 8 7 5 9 5
Otherc 0 0 0 0 0
Region of residenced
Northeast 0 0 0 0 0
Midwest 1 1 0 1 0
South 2 5 3 1 4
West 6 4 7 10 3
U.S. dependent areas 0 0 0 0 0
Subtotal, female ≥50 years of age 9 10 10 12 7
Total, ≥50 years of age at diagnosis 26 24 30 33 30

Asian

Table 5b. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States and 6 dependent areas
Asian
2014 2015 2016 2017 2018
No. No. No. No. No.
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 49 55 61 62 51
Injection drug use 2 4 4 2 3
Male-to-male sexual contact and injection drug use 3 1 1 0 1
Heterosexual contactb 11 11 12 9 13
Otherc 0 0 0 0 1
Region of residenced
Northeast 18 14 14 14 19
Midwest 3 8 13 3 5
South 11 14 18 14 14
West 32 35 34 42 30
U.S. dependent areas 1 0 0 0 0
Subtotal, male aged 50–64 years 65 71 79 73 68
Female adult
Transmission Categorya
Injection drug use 3 2 1 2 1
Heterosexual contactb 21 18 21 28 22
Otherc 0 0 0 1 0
Region of residenced
Northeast 1 5 5 6 11
Midwest 4 3 1 2 0
South 4 4 4 8 7
West 15 8 12 14 5
U.S. dependent areas 0 0 0 0 0
Subtotal, female aged 50–64 years 24 20 22 30 23
Aged ≥65 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 8 5 10 8 10
Injection drug use 1 1 1 0 1
Male-to-male sexual contact and injection drug use 0 0 1 0 0
Heterosexual contactb 6 4 6 2 6
Otherc 0 0 1 1 0
Region of residenced
Northeast 5 3 6 1 4
Midwest 2 0 3 2 0
South 1 1 3 4 4
West 7 6 7 4 9
U.S. dependent areas 0 0 0 0 0
Subtotal, male aged ≥65 years 15 10 19 11 17
Female adult
Transmission Categorya
Injection drug use 0 0 0 0 0
Heterosexual contactb 1 4 5 5 7
Otherc 0 1 0 0 0
Region of residenced
Northeast 1 0 2 1 2
Midwest 0 0 1 1 0
South 0 2 0 2 2
West 0 3 2 1 3
U.S. dependent areas 0 0 0 0 0
Subtotal, female aged ≥65 years 1 5 5 5 7
Aged ≥50 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 57 60 72 70 61
Injection drug use 3 5 5 2 4
Male-to-male sexual contact and injection drug use 3 1 2 0 1
Heterosexual contactb 16 14 18 11 19
Otherc 1 1 1 1 1
Region of residenced
Northeast 23 17 20 15 23
Midwest 5 8 16 5 5
South 12 15 21 18 18
West 39 41 41 46 39
U.S. dependent areas 1 0 0 0 0
Subtotal, male ≥50 years of age 80 81 98 84 85
Female adult
Transmission Categorya
Injection drug use 3 2 1 2 1
Heterosexual contactb 22 22 26 33 28
Otherc 0 1 0 1 1
Region of residenced
Northeast 2 5 7 7 13
Midwest 4 3 2 3 0
South 4 6 4 10 9
West 15 11 14 15 8
U.S. dependent areas 0 0 0 0 0
Subtotal, female ≥50 years of age 25 25 27 35 30
Total, ≥50 years of age at diagnosis 105 106 125 119 115

Black/African American

Table 5b. Diagnoses of HIV infection among adults aged 50 years and older, by race/ethnicity, age group, sex at birth, and region of residence, 2014-2018—United States and 6 dependent areas
Black/African American
2014 2015 2016 2017 2018
No. No. No. No. No.
Aged 50–64 years of age at diagnosis
Male adult
Transmission Categorya
Male-to-male sexual contact 664 654 681 665 628
Injection drug use 180 158 144 136 130
Male-to-male sexual contact and injection drug use 47 32 30 41 33
Heterosexual contactb 563 604 540 518 479
Otherc 3 2 2 3 3
Region of residenced
Northeast 321 288 228 255 240
Midwest 152 169<